Quarterlytics / Industrials / Manufacturing - Metal Fabrication / AZZ

AZZ

azz · TSX Industrials
Claim this profile
Ticker azz
Exchange TSX
Sector Industrials
Industry Manufacturing - Metal Fabrication
Employees 1-10
← All annual reports
FY2019 Annual Report · AZZ
Sign in to download
Loading PDF…
Azarga Uranium Corp. 
CONSOLIDATED FINANCIAL STATEMENTS 

December 31, 2019 
(Expressed in U.S. Dollars) 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tel: 604-688-5421
Fax: 604-688-5132
www.bdo.ca

BDO Canada LLP
600 Cathedral Place
925 West Georgia Street
Vancouver, BC
V6C 3L2

Independent Auditor’s Report

To the Shareholders of Azarga Uranium Corp.

Opinion

We  have  audited  the  accompanying  consolidated financial  statements  of  Azarga  Uranium  Corp.  (“the
Company”), which comprise the consolidated statements of financial position as at December 31, 2019
and 2018 and the related consolidated statements of loss and other comprehensive loss, changes in equity
and cash flows for the years then ended,  and a  summary  of  significant  accounting  policies  and other
explanatory information.

In  our  opinion,  the  accompanying  consolidated  financial  statements  present  fairly,  in  all  material
respects,  the  financial  position  of  Azarga  Uranium  Corp.  as  at  December  31,  2019  and  2018  and  the
consolidated statements of loss and other comprehensive loss, changes in equity and cash flows for the
years then ended, and a summary of significant accounting policies and other explanatory information in
accordance with International Financial Reporting Standards (“IFRS”).

Basis for Opinion

We  conducted  our  audit  in  accordance  with  Canadian  generally  accepted  auditing  standards.  Our
responsibilities  under  those  standards  are  further  described  in  the Auditor’s  Responsibilities  for  the
Audit  of  the  Consolidated  Financial  Statements  section  of  our  report.  We  are  independent  of  the
Company in accordance with the ethical requirements that are relevant to our audit of the consolidated
financial  statements  in  Canada,  and we  have fulfilled our other ethical  responsibilities  in  accordance
with  these  requirements.  We  believe  that  the  audit  evidence  we  have  obtained  is  sufficient  and
appropriate to provide a basis for our opinion.

Material Uncertainty Related to Going Concern

We draw attention to Note 1 in the consolidated financial statements, which indicates that the Company
has not generated revenues from operations, is currently in the exploration and development stage and
has an accumulated deficit of $26,988,501. These events or conditions, along with other matters as set
forth  in  Note  1,  indicate  that  material  uncertainties  exist  that  may  cast  significant  doubt  on  the
Company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

Other Information

Management is responsible for the other information. The other information comprises:

·

The information, other than the consolidated financial statements and our auditor’s report thereon,
included in Management’s Discussion & Analysis.

Our opinion on the consolidated financial statements does not cover the other information and we do
not express any form of assurance conclusion thereon.

In connection with our audit of the consolidated financial statements, our responsibility is to read the
other information identified above and, in doing so, consider whether the other information is materially
inconsistent  with  the  consolidated  financial  statements  or  our  knowledge  obtained  in  the  audit,  or
otherwise appears to be materially misstated.

We obtained Management’s Discussion & Analysis prior to the date of this auditor’s report. If, based on
the  work  we  have  performed  on  this  other  information,  we  conclude  that  there  is  a  material
misstatement of this other information, we are required to report that fact in this auditor’s report. We
have nothing to report in this regard.

BDO Canada LLP, a Canadian limited liability partnership, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the
international BDO network of independent member firms.

Page 1 of 12

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial
Statements

Management  is  responsible  for  the  preparation  and  fair  presentation  of  these  consolidated  financial
statements in accordance with IFRS, and for such internal control as management determines is necessary
to enable the preparation of consolidated financial statements that are free from material misstatement,
whether due to fraud or error.

In  preparing  the  consolidated  financial  statements,  management  is  responsible  for  assessing  the
Company’s  ability to  continue  as  a  going  concern,  disclosing,  as  applicable,  matters  related  to  going
concern and using the going concern basis of accounting unless management either intends to liquidate
the Company or to cease operations, or has no realistic alternative but to do so.

Those charged with governance are responsible for overseeing the Company’s financial reporting process.

Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements
as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s
report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee
that an audit conducted in accordance with Canadian generally accepted auditing standards will always
detect  a  material  misstatement  when  it  exists.  Misstatements  can  arise  from  fraud  or  error  and  are
considered material if, individually or in the aggregate, they could reasonably be expected to influence
the economic decisions of users taken on the basis of these consolidated financial statements.

As  part  of  an  audit  in  accordance  with  Canadian  generally  accepted  auditing  standards,  we  exercise
professional judgment and maintain professional skepticism throughout the audit. We also:

·

Identify  and  assess  the  risks  of  material  misstatement  of  the  consolidated  financial  statements,
whether due to fraud or error, design and perform audit procedures responsive to those risks, and
obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk
of not detecting a material misstatement resulting from fraud is higher than for one resulting from
error,  as  fraud  may  involve  collusion,  forgery,  intentional  omissions,  misrepresentations,  or  the
override of internal control.

· Obtain an understanding of internal control relevant to the audit in order to design audit procedures
that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company’s internal control.

·

·

·

Evaluate  the  appropriateness  of  accounting  policies  used  and  the  reasonableness  of  accounting
estimates and related disclosures made by management.

Conclude on the appropriateness of management’s use of the going concern basis of accounting and,
based on the  audit  evidence obtained, whether  a  material uncertainty  exists related to events or
conditions that may cast significant doubt on the Company’s ability to continue as a going concern.
If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s
report to the related disclosures in the consolidated financial statements or, if such disclosures are
inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to
the date of our auditor’s report. However, future events or conditions may cause the Company to
cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the consolidated financial statements,
including  the  disclosures,  and  whether  the  consolidated  financial  statements  represent  the
underlying transactions and events in a manner that achieves fair presentation.

· Obtain sufficient appropriate audit evidence regarding the financial information of the entities or
business activities within the group to express an opinion on the consolidated financial statements.
We  are  responsible  for the direction,  supervision  and  performance of the group  audit.  We  remain
solely responsible for our audit opinion.

We  communicate  with  those  charged  with  governance  regarding,  among  other  matters,  the  planned
scope  and  timing  of  the  audit  and  significant  audit  findings,  including  any  significant  deficiencies  in
internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant
ethical requirements regarding independence, and to communicate with them all relationships and other
matters  that  may  reasonably  be  thought to bear on our  independence,  and  where applicable, related
safeguards.

The engagement partner on the audit resulting in this independent auditor’s report is Bryndon Kydd.

(signed) “BDO Canada LLP”

Chartered Professional Accountants
Vancouver, British Columbia

March 26, 2020

TABLE OF CONTENTS

CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Statements of Financial Position
Consolidated Statements of Loss and Other Comprehensive Loss
Consolidated Statements of Changes in Equity
Consolidated Statements of Cash Flows
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

1. Corporate information and going concern
2. Basis of presentation
3. Summary of significant accounting policies
4. Segmented information
5. Acquisition of URZ Energy
6. Exploration and evaluation assets
7. Loans payable
8. Decommissioning liabilities
9. Warrant liabilities

10. Equity
11. Share option reserve
12. Administrative expenses
13. Finance costs
14. Discontinued operations
15. Related party transactions and balances
16. Financial instruments and risk management
17. Capital risk management
18. Commitments
19. Supplemental cash flow information
20. Non-controlling interest
21. Deferred income tax
22. Subsequent events

Page

6
7
8
9

10
11
14
26
27
29
34
35
35
36
40
42
42
43
43
45
49
49
50
51
53
55

 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Consolidated Statements of Financial Position 
(Expressed in U.S. Dollars) 

ASSETS

Current assets

Cash
Total current assets
Other assets

Non-current assets

Restricted cash
Exploration and evaluation assets
Property, plant and equipment
Right-of-use assets
Total non-current assets
Reclamation bonds
Total assets

LIABILITIES AND EQUITY

Current liabilities

Trade and other payables 
Total current liabilities
Operating lease obligations

Non-current liabilities

Trade and other payables 
Deferred income tax liabilities
Decommissioning liabilities
Operating lease obligations
Total non-current liabilities
Warrant liabilities
Total liabilities

Equity

Common shares
Contributed surplus
Share option reserve
Foreign currency translation reserve
Accumulated deficit
Equity attributable to the equity holders of the Company
Total equity
Non-controlling interest
Total liabilities and equity

Notes

2019

2018

As at December 31,

$                     

184,447
23,913
208,360

$                     

352,001
26,810
378,811

22,716
41,440,616
67,577
111,357
-

41,642,266
41,850,626

$               

39,963
46,696,473
90,106
-
99,000
46,925,542
47,304,353

$               

$                     

793,864
45,014
838,878

$                  

1,302,085

-

1,302,085

70,000
3,112,193
251,550
70,445
265,029
3,769,217
4,608,095

60,303,924
1,117,679
2,809,429

-

(26,988,501)
37,242,531

-

37,242,531
41,850,626

$               

150,000
4,233,790
223,442
-
247,654
4,854,886
6,156,971

57,976,321
1,001,818
2,500,078
(863,092)
(18,973,266)
41,641,859
(494,477)
41,147,382
47,304,353

$               

6

8

15
21
8

9

10
10
11

20

Corporate information and going concern
Approved by the Board of Directors of the Company: 

1

“Joseph L. Havlin”, Director 

“Matthew O’Kane”, Director 

The accompanying notes are an integral part of these consolidated financial statements. 

Page | 6 

 
 
 
 
 
    
 
 
                           
                           
                        
                        
                           
                           
                  
                  
                           
                           
                        
                                  
                                  
                           
                  
                  
                           
                                  
                        
                    
                           
                        
                    
                    
                        
                        
                           
                                  
                        
                        
                    
                    
                    
                    
                  
                  
                    
                    
                    
                    
                                  
                      
                
                
                  
                  
                                  
                      
                  
                  
AZARGA URANIUM CORP. 
Consolidated Statements of Loss and Other Comprehensive Loss 
(Expressed in U.S. Dollars) 

Administrative expenses
Foreign exchange loss
Loss from operations
Impairment of exploration and evaluation assets

Finance costs
Gain on settlement of trade and other payables
Loss before income tax
Unrealized gain on warrant liabilities

Net loss from continuing operations
Deferred income tax recovery (expense)

Net loss
Net loss from discontinued operations

Net loss attributable to:

Equity holders of the Company
Net loss
Non-controlling interest

Basic and diluted loss per share

Notes

Year ended December 31,
2019
2018

12

6

13
10
9

21

14

20

$                

(1,943,285)
(93,382)
(2,422,398)
(4,459,065)
(9,734)
-
371,983
(4,096,816)
122,000
(3,974,816)
(3,763,180)
(7,737,996)

$                

(2,040,580)
(946)
-

(2,041,526)
(154,913)
34,485
51,789
(2,110,165)
(181,000)
(2,291,165)
(117,560)
(2,408,725)

(7,464,073)
(273,923)
(7,737,996)

$                

(2,379,290)
(29,435)
(2,408,725)

$                

Basic and diluted loss per share from continuing operations
Basic and diluted loss per share from discontinued operations
Weighted average number of common shares outstanding
Basic and diluted loss per share

Net loss
Other comprehensive income (loss)
Item that may be reclassified subsequently as profit or loss

Total other comprehensive loss
Foreign currency translation adjustment 

Other comprehensive income (loss) attributable to:

$                           
$                           
$                           

(0.02)
(0.02)
(0.04)

$                           
$                           
$                           

(0.02)
(0.00)
(0.02)

181,477,536

125,183,747

$                

(7,737,996)

$                

(2,408,725)

1,080,330
(6,657,666)

$                

(50,154)
(2,458,879)

$                

Equity holders of the Company
Other comprehensive income (loss)
Non-controlling interest

20

1,065,341
14,989
1,080,330

$                  

(35,108)
(15,046)
(50,154)

$                      

The accompanying notes are an integral part of these consolidated financial statements. 

Page | 7 

 
 
 
 
 
 
 
 
 
 
 
                         
                               
                  
                                  
                  
                  
                           
                      
                                  
                           
                        
                           
                  
                  
                        
                      
                  
                  
                  
                      
                  
                  
                  
                  
                      
                         
               
               
                    
                         
                    
                         
                           
                         
AZARGA URANIUM CORP. 
Consolidated Statements of Changes in Equity 
(Expressed in U.S. Dollars) 

Attributable to equity holders of the Company

Number of
shares

Common
shares

Contributed
surplus

Share option 
reserve

Foreign currency
translation
reserve

Accumulated
deficit

Total equity

Non-controlling
interest

Total equity

Balances, December 31, 2018

Issuance of shares for private placement
Issuance of shares to settle employee 
remuneration
Issuance of shares to settle ESPP
Issuance of shares to settle DSA
Compensation to be settled by equity
Share-based compensation
NCI adjustment on acquisition of 23.1% of UrAsia
Net loss for the year
Balances, December 31, 2019
Other comprehensive income for the year

169,833,806
13,106,046

$   

57,976,321
1,871,110

900,000
1,380,521
323,553

-
-
-
-
-

170,068
231,424
55,001
-
-
-
-
-

185,543,926

$   

60,303,924

$     

1,001,818

$     

2,500,078

$           

(863,092)

$ 

(18,973,266)

-

(170,068)
(231,424)
(55,001)
572,354

-
-
-
-

-

-
-
-
-

309,351

-
-
-

-

-
-
-
-
-

(202,249)

-

1,065,341

$     
2,809,429
Attributable to equity holders of the Company

$                      
-

1,117,679

$     

-

-
-
-
-
-

(551,162)
(7,464,073)

-

$ 

(26,988,501)

$   

41,641,859
1,871,110

-
-
-

572,354
309,351
(753,411)
(7,464,073)
1,065,341
37,242,531

$   

$       

(494,477)

-

-
-
-
-
-

753,411
(273,923)
14,989
$                  
-

$      

41,147,382
1,871,110

-
-
-

572,354
309,351

-

(7,737,996)
1,080,330
37,242,531

$      

Number of
shares

Common
shares

Contributed
surplus

Share option 
reserve

Foreign currency
translation
reserve

Accumulated
deficit

Total equity

Non-controlling
interest

Total equity

Balances, December 31, 2017

Acquisition of URZ Energy
Issuance of shares to settle Shareholders' Loan
Issuance of shares for private placements
Issuance of shares on exercise of warrants
Issuance of shares for repurchase of royalties
Issuance of shares to settle trade and other 
payables
Issuance of shares to settle employee 
remuneration
Issuance of shares to settle ESPP
Issuance of shares to settle DSA
Issuance of warrants
Compensation to be settled by equity
Share-based compensation
Net loss for the year
Balances, December  31, 2018
Other comprehensive loss for the year

83,619,850
58,107,109
11,269,243
780,000
11,950,866
104,166

$   

41,286,853
11,273,920
2,201,024
140,804
2,347,295
19,391

2,033,334

391,014

550,000
1,115,301
303,937

-
-
-
-
-

93,500
215,344
58,669
(51,493)
-
-
-
-

$         

768,652
686,314

$     

1,427,563
769,169

-
-

(520,217)

-

-

(93,500)
(215,344)
(58,669)
-

434,582

-
-
-

-
-
-
-

-

-
-
-
-
-

303,346

-
-

169,833,806

$   

57,976,321

$     

1,001,818

$     

2,500,078

$           

(827,984)

$ 

(16,593,976)

-
-
-
-
-

-

-
-
-
-
-
-
-
(35,108)
(863,092)

$           

-
-
-
-
-

-

-
-
-
-
-
-

(2,379,290)

-

$ 

(18,973,266)

$   

26,061,108
12,729,403
2,201,024
140,804
1,827,078
19,391

391,014

-
-
-
(51,493)
434,582
303,346
(2,379,290)
(35,108)
41,641,859

$   

$       

(449,996)

-
-
-
-
-

-

-
-
-
-
-
-
(29,435)
(15,046)
(494,477)

$       

$      

25,611,112
12,729,403
2,201,024
140,804
1,827,078
19,391

391,014

-
-
-
(51,493)
434,582
303,346
(2,408,725)
(50,154)
41,147,382

$      

The accompanying notes are an integral part of these consolidated financial statements. 

Page | 8 

 
 
 
   
     
        
                    
                    
                        
                    
        
                    
           
           
           
         
                    
                        
                    
                    
                    
                       
        
           
         
                    
                        
                    
                    
                    
                       
           
             
            
                    
                        
                    
                    
                    
                       
                    
                    
           
                    
                        
                    
           
                    
              
                    
                    
                    
           
                        
                    
           
                    
              
                    
                    
                    
                    
             
         
         
           
                       
                    
                    
                    
                    
                        
      
      
         
         
                    
                    
                    
                    
            
                    
        
             
           
   
 
     
     
     
           
           
                        
                    
     
                    
         
     
        
                    
                    
                        
                    
        
                    
           
           
           
                    
                    
                        
                    
           
                    
              
     
        
         
                    
                        
                    
        
                    
           
           
             
                    
                    
                        
                    
             
                    
                 
        
           
                    
                    
                        
                    
           
                    
              
           
             
            
                    
                        
                    
                    
                    
                       
        
           
         
                    
                        
                    
                    
                    
                       
           
             
            
                    
                        
                    
                    
                    
                       
                    
            
                    
                    
                        
                    
            
                    
               
                    
                    
           
                    
                        
                    
           
                    
              
                    
                    
                    
           
                        
                    
           
                    
              
                    
                    
                    
                    
                        
      
      
            
         
                    
                    
                    
                    
                
                    
            
            
               
   
AZARGA URANIUM CORP. 
Consolidated Statements of Cash Flows 
(Expressed in U.S. Dollars) 

OPERATING ACTIVITIES

Net loss from continuing operations
Adjustments for:
Depreciation
Share-based compensation
Impairment of exploration and evaluation assets
Gain on settlement of trade and other payables
Unrealized gain on warrant liabilities
Deferred income tax expense (recovery)
Equity compensation expense
Finance costs
Unrealized foreign exchange (gain) loss

Operating cash flows before changes in non-cash working capital items

Change in other assets
Change in trade and other payables

Net cash used in operating activities of continuing operations
Net cash used in operating activities of discontinued operations

INVESTING ACTIVITIES

Cash received on acquisition of URZ Energy, net of transaction costs
Expenditures on exploration and evaluation assets
Recoveries of expenditures on exploration and evaluation assets
Sale of property, plant and equipment
Net cash used in investing activities of continuing operations
Reclamation bonds
Net cash generated by financing activities of discontinued 
operations

Notes

Year ended December 31,
2019
2018

$                

(3,974,816)

$                

(2,291,165)

11
6
10
9
21
10
13

5
6
6

8

44,560
252,790
2,422,398

-
(371,983)
(122,000)
572,354
9,734
12,277
(1,154,686)
2,897
(296,541)
(1,448,330)
(41,176)

-

(1,316,974)
2,000
1,126
99,000
(1,214,848)

2,696
266,044
-
(34,485)
(51,789)
181,000
434,582
154,913
(75,398)
(1,413,602)
145,542
(465,357)
(1,733,417)
(117,560)

423,924
(1,304,967)

-
-
(2,000)
(883,043)

FINANCING ACTIVITIES

99,700

260,172

10
Proceeds from issuance of common shares 
10
Share issue costs
Loan proceeds received
7
Net cash generated by financing activities of continuing operations
Payment of other loans payable
7
Net cash generated by financing activities of discontinued 
operations

Decrease in cash from continuing operations
Effect of foreign exchange rate changes on cash
Increase in cash from discontinued operations
Cash, beginning of year

Cash, end of year

2,266,169
(16,553)
-
-

2,249,616

191,409

(3,925)

(417,487)
249,933
352,001

1,984,444

-
515,000
(105,000)
2,394,444

-

(787)

(222,803)
142,612
432,192

Supplemental cash flow information, see Note 19 

$                     

184,447

$                     

352,001

The accompanying notes are an integral part of these consolidated financial statements. 

Page | 9 

 
 
 
 
 
                           
                             
                        
                        
                    
                                  
                                  
                         
                      
                         
                      
                        
                        
                        
                             
                        
                           
                         
                  
                  
                             
                        
                      
                      
                  
                  
                         
                      
                                  
                        
                  
                  
                             
                                  
                             
                                  
                           
                           
                  
                      
                           
                        
                    
                    
                         
                                  
                                  
                        
                                  
                      
                    
                    
                        
                                  
                           
                               
                      
                      
                        
                        
                        
                        
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
1. 

CORPORATE INFORMATION AND GOING CONCERN

Azarga Uranium Corp. (“Azarga Uranium”) was incorporated on February 10, 1984 under the 
laws  of  the  Province  of  British  Columbia,  Canada.  Azarga  Uranium’s  common  shares  are 
publicly traded on the Toronto Stock Exchange (“TSX”) (Symbol: AZZ), the Frankfurt Stock 
Exchange  (Symbol:  P8AA),  and  the  OTCQB  Venture  Market  (Symbol:  AZZUF).  Azarga 
Uranium,  together  with  its  subsidiaries  (collectively  referred  to  as  the  “Company”),  is  an 
integrated uranium exploration and development company.  

The Company controls uranium properties located in the United States of America (“USA”) 
with a primary focus of developing in-situ recovery uranium projects.  The Company’s Dewey 
Burdock Project, located in South Dakota, USA, is the Company’s initial development priority. 
The  Company  also  owns uranium  projects  in  Wyoming,  Colorado,  and  Utah.    Until  sold  in 
October 2019, the Company also held an interest in a project in the Kyrgyz Republic, see Note 
6. 

The Company’s corporate and registered and records office address is Unit 1 – 15782 Marine 
Drive, White Rock, BC, V4B 1E6. 

These consolidated financial statements have been prepared on a going concern basis, which 
contemplates that the Company will continue operations for the foreseeable future and will 
be able to realize its assets and discharge its liabilities in the normal course of business as 
they  fall  due.  To  date,  the  Company  has  not  generated  revenues  from  operations  and  is 
currently in the exploration and development stage.  As at December 31, 2019, the Company 
had a working capital deficit of $630,518 and an accumulated deficit of $26,988,501 and will 
continue incurring losses for the foreseeable future.  Additional funding will be required by 
the Company to complete its strategic objectives and continue as a going concern. There is no 
certainty  that  additional  financing,  at  terms  that  are  acceptable  to  the  Company,  will  be 
available.  Further,  at  present,  the  COVID-19  pandemic  is  negatively  impacting  financial 
markets globally and this may adversely affect the Company’s ability to raise capital for future 
operations  and  exploration  and  development  of  the  Company’s  mineral  properties.    The 
Company has successfully raised financing in the past and will continue to assess available 
alternatives; however, there is no assurance that the Company will be able to raise additional 
funds  in  the  future.  These  material  uncertainties  cast  significant  doubt  on  the  Company’s 
ability to continue as a going concern. 

These consolidated financial statements do not reflect adjustments that would be necessary 
if the going concern assumption were not appropriate. 

Page | 10 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
2.  

BASIS OF PRESENTATION 

2.1 

Statement of compliance 

These  consolidated  financial  statements,  including  comparatives,  have  been  prepared  in 
accordance  with  and  using  accounting  policies  in  compliance  with  International  Financial 
Reporting  Standards  (“IFRS”)  and  interpretations  issued  by  the  International  Accounting 
Standards  Board  (“IASB”)  and  interpretations  of  the  IFRS  Interpretations  Committee 
(“IFRIC”). 

These  consolidated  financial  statements  for  the  year  ended  December  31,  2019  were 
approved and authorized for issue by the Company’s Board of Directors on March 26, 2020. 
Basis of presentation 

2.2  

These consolidated financial statements have been prepared on a historical cost basis, except 
for  financial  instruments  which  are  measured  at  fair  value.  The  Company’s  financial 
instruments are further disclosed in Note 16. 
Presentation currency 

2.3 

These  consolidated  financial  statements  are  presented  in  United  States  Dollars,  unless 
otherwise indicated.  All references to $ refer to the United States Dollar and all references to 
C$ refer to the Canadian Dollar. 
Significant accounting judgments and estimates 

2.4 

Information  about  judgments  and  estimates  in  applying  accounting  policies  that  have  the 
most significant effect on the amounts recognized in the consolidated financial statements 
are as follows: 
Liquidity and going concern assumption 

In  the  determination  of  the  Company’s  ability  to  meet  its  ongoing  obligations  and  future 
contractual  commitments,  management  relies  on  the  Company’s  planning,  budgeting  and 
forecasting process to help determine the funds required to support the Company’s normal 
operations  on  an  ongoing  basis  and  its  expansionary  plans.    The  key  inputs  used  by  the 
Company  in  this  process  include  forecasted  capital  deployment,  progress  on  permitting, 
results  from  the  exploration  and  development  of  its  properties  and  general  industry 
conditions.    Changes  in  these  inputs  may  alter  the  Company’s  ability  to  meet  its  ongoing 
obligations  and  future  contractual  commitments  and  could  result  in  adjustments  to  the 
amounts  and  classifications  of  assets  and  liabilities  should  the  Company  be  unable  to 
continue as a going concern, see Note 1. 

Page | 11 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
2.  

BASIS OF PRESENTATION (Continued) 

2.4 

Significant accounting judgments and estimates (Continued) 

Indicators of impairment of exploration and evaluation assets 

In accordance with the Company’s accounting policy for its exploration and evaluation assets, 
expenditures  on  its  uranium  properties  are  capitalized.  There  is  no  certainty  that  the 
expenditures made by the Company in the exploration of its property interests will result in 
discoveries  of  commercial  quantities  of  uranium.  The  Company  applies  judgment  to 
determine whether indicators of impairment exist for these capitalized costs. 

Management uses several criteria in making this assessment, including the period for which 
the  Company  has  the  right  to  explore,  expected  renewals  of  exploration  rights,  whether 
substantive  expenditures  on  further  exploration  and  evaluation  of  its  properties  are 
budgeted,  and  evaluation  of  the  results  of  exploration  and  evaluation  activities  up  to  the 
reporting date. 
Carrying value of exploration and evaluation assets 

If any indicators of impairment are noted then management reviews the carrying value of the 
Company’s exploration and evaluation assets to determine whether an impairment charge 
should be recorded on any of its projects.  Management determines the recoverable amount 
of its individual exploration and evaluation assets using the higher of fair value less costs to 
sell  or  value-in-use.    This  determination  and  the  individual  assumptions  require  that 
management  decide  whether  impairment  should  be  recorded  based  on  the  best  available 
information at each reporting period.  Changes in these assumptions may alter the results of 
impairment  testing,  impairment  charges  recognized  in  profit  or  loss  and  the  resulting 
carrying amounts of assets. 

During the year ended December 31, 2019, the Company recorded an impairment charge of 
$4,140,444 on its Kyzyl Ompul project in Kyrgyzstan and an impairment charge of $2,422,398 
on its Centennial project in Colorado, see Note 6. 

Page | 12 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
2.  

BASIS OF PRESENTATION (Continued) 

2.4 

Significant accounting judgments and estimates (Continued) 

Capitalization of exploration and evaluation costs  

Management  has  determined  that  exploration  and  evaluation  costs  incurred  or  acquired 
during  the  year  will  have  future  economic  benefits  and  are  economically  recoverable.  In 
making this judgment, management has assessed various sources of information including, 
but  not  limited  to,  the  geologic  and  metallurgic  information,  scoping  studies,  preliminary 
economic  assessments,  proximity  of  operating  facilities,  operating  management  expertise 
and existing permits. 
Determining if an acquisition is a business combination or an asset acquisition 

Business  Combinations

As  required  by  IFRS  3 
  (“IFRS  3”),  the  Company  is  required  to 
determine  whether  the  acquisition  of  URZ  Energy  should  be  accounted  for  as  a  business 
combination or an asset acquisition, see Note 5.  Under IFRS 3, the components of a business 
must include inputs, processes and outputs. Management has determined that URZ Energy 
did not include all the necessary components of a business. Accordingly, the acquisition of 
URZ  Energy  has  been  recorded  as  an  acquisition  of  URZ  Energy’s  net  assets,  consisting 
principally of exploration and evaluation assets and working capital.   
Identifying the acquirer in an acquisition 

Consolidated  Financial  Statements

,  the  Company  is 
As  required  by  IFRS  3  and  IFRS  10 
required to determine whether it is the acquirer or acquiree in the URZ Energy acquisition.  
The acquirer is the entity that obtains control of the acquiree in the acquisition.  If it is not 
clear which company is the acquirer, additional information must be considered, such as the 
combined  entity’s  relative  voting  rights,  existence  of  a  large  minority  voting  interest, 
composition  of  the  governing  body  and  senior  management,  and  the  terms  behind  the 
exchange  of  equity  interests.    Management  has  determined  that  Azarga  Uranium  is  the 
acquirer of URZ Energy. 
Determination of asset and liability fair values  

Business combinations and asset acquisitions require judgment and estimates to be made at 
the  date  of  acquisition  in  relation  to  determining  asset  and  liability  fair  values.    The 
information necessary to measure the fair values as at the acquisition date of assets acquired 
and liabilities assumed requires management make certain judgments and estimates about 
future  events,  including  but  not  limited  to  estimates  of  mineral  resources  acquired, 
exploration potential, future operating costs and capital expenditures, future metal prices, 
and long-term foreign exchange rates. 

Page | 13 

 
 
 
 
 
 
 
 
 
 
 
  
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

3.1 

Basis of consolidation 

The consolidated  financial  statements include  the  financial  statements  of  Azarga Uranium 
and its controlled subsidiaries. 

Name of subsidiary 

Powertech (USA) Inc. 

Ucolo Exploration Corp. * 

UrAsia in Kyrgyzstan LLC ** 

URZ Energy Corp. * 
Azarga Resources Limited 
Azarga Resources (Hong 
Kong) Limited 
Azarga Resources Canada 
Ltd. 
Azarga Resources USA 
Company 

Place of 
incorporation 

Ownership 
interest 
at December 
31, 2019 

USA 

USA 

Kyrgyz 
Republic 
Canada 
BVI 

Hong Kong 

100% 

100% 

0% 

100% 
100% 

100% 

Principal activity 

Operating uranium 
exploration company 
Operating uranium 
exploration company 
Operating uranium 
exploration company 
Holding company 
Holding company 

Holding company 

Canada 

100% 

Holding company 

USA 

100% 

Holding company 

* acquired in July 2018, see Note 5 
** sold in October 2019, see Note 6 

The Company controls an entity when the Company is exposed to, or has rights to, variable 
returns  from  its  involvement  with  the  entity  and  has  the  ability  to  affect  those  returns 
through its power over the entity.   

The  results  of  subsidiaries  acquired  or  disposed  of  during  the  year  are  included  in  the 
consolidated statements of profit or loss and other comprehensive income or loss from the 
effective  date  of  acquisition  or  up  to  the  effective  date  of  disposal,  as  appropriate.    All 
intercompany transactions, balances, income and expenses are eliminated on consolidation. 

Page | 14 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.2 

Foreign currency translation 

The functional currency of each entity is determined by the currency of the primary economic 
environment  in  which  the  entity  operates.    The  functional  currency  of  each  entity  is  the 
United  States  Dollar,  with  the  exception  of  UrAsia  in  Kyrgyzstan  LLC,  whose  functional 
currency is the Kyrgyz Som.  
Transactions and balances 

Foreign currency transactions are translated into the functional currency using the exchange 
rates  prevailing  at  the  dates  of  the  transactions.  Foreign  currency  monetary  items  are 
translated at the period-end exchange rate. Non-monetary items measured at historical cost 
continue to be carried at the exchange rate at the date of the transaction. Non-monetary items 
measured at fair value are reported at the exchange rate at the date when fair values were 
determined. 

Exchange  differences  arising  on  the  translation  of  monetary  items  or  on  settlement  of 
monetary items are recognized in profit or loss in the consolidated statements of profit or 
loss and other comprehensive income or loss in the period in which they arise. 

Exchange  differences  arising  on  the  translation  of  non-monetary  items  are  recognized  in 
other comprehensive income or loss in the consolidated statements of profit or loss and other 
comprehensive  income  or  loss  to  the  extent  that  gains  and  losses  arising  on  those  non-
monetary items are also recognized in other comprehensive income or loss. Where the non-
monetary  gain  or  loss  is  recognized  in  profit  or  loss,  the  exchange  component  is  also 
recognized in profit or loss.  
Parent and subsidiary companies  

The financial position and results of operations whose functional currency is different from 
the presentation currency are translated as follows:  
• 

Assets  and  liabilities  are  translated  at  period-end  exchange  rates  prevailing  at  that 
reporting date; and  

• 

Income and expenses are translated at the average exchange rates for the period.  

Exchange differences are transferred directly to other comprehensive income or loss and are 
included in a separate component of shareholders’ equity titled foreign currency translation 
reserve.  These  differences  are  recognized  in  profit  or  loss  in  the  period  in  which  the 
subsidiary is disposed of.  

Page | 15 

 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.3 

Restricted cash 

Restricted cash consists of deposits held for collateral pursuant to bonds provided to state 
authorities in connection with exploration and evaluation property activities. The Company 
makes such cash deposits for restoration provisions related to rehabilitation obligations. 
Property, plant and equipment 

3.4 

Property, plant and equipment (“PPE”) includes the Company’s machinery and equipment, 
office  equipment,  furniture  and  fixtures,  vehicles  and  buildings.  PPE  is  stated  at  cost  less 
accumulated depreciation and accumulated impairment losses.   
Initial recognition 

The  cost  of  an  item  of  PPE  consists  of  the  purchase  price  or  construction  cost,  including 
vendor prepayments, any costs directly attributable to bringing the asset to the location and 
condition necessary for its intended use, borrowing costs during construction, if applicable, 
and the estimated costs associated with dismantling and removing the assets.  
Depreciation  

Depreciation is recorded based on the cost of an item of PPE, less its estimated residual value, 
using the straight-line method over the following estimated useful lives: 
• 
• 
• 
• 
• 

Machinery and equipment  
Vehicles 
Office equipment 
Furniture and fixtures 
Building 

5 to 10 years 
3 years 
3 to 5 years 
4 to 5 years 
10 to 40 years  

When major components of an item of PPE have different useful lives, they are accounted for 
as separate items of PPE and depreciated as per each component’s useful life. 

The cost of replacing a component of PPE is recognized as part of the carrying value of the 
item if it is probable that the future economic benefit will flow to the Company and its cost 
can be measured.  The carrying amount of the replaced component is derecognized.  

Page | 16 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.4 

Property, plant and equipment (Continued) 

An item of PPE is derecognized upon disposal, when held for sale or when no future economic 
benefits are expected to arise from the continued use of the asset.  Any gain or loss arising on 
disposal of the asset, determined as the difference between the net disposal proceeds and the 
carrying amount of the asset, is recognized in profit or loss. 

The Company conducts an annual assessment of the residual balances, estimated useful lives 
and depreciation methods being used for PPE and any changes arising from the assessment 
are applied by the Company prospectively. 
Exploration and evaluation assets 

3.5 

Exploration and evaluation expenditures are recognized as assets in the period in which they 
are incurred once the legal right to explore a property has been acquired. This includes any 
acquisition costs associated with such property. These direct expenditures include such costs 
as drilling/engineering, salaries and consulting, rehabilitation costs and license fees, inclusive 
of land payments and claims maintenance. Costs not directly attributable to exploration and 
evaluation activities, including general and administrative overhead costs, are expensed in 
the period in which they occur.  Payments received by the Company from exploration and 
evaluation  partners  are  credited  to  the  capitalized  cost  of  the  exploration  and  evaluation 
asset.  If the payments received exceed the capitalized cost of the exploration and evaluation 
asset, the excess is recognized as a gain. 

The  Company  assesses  exploration  and  evaluation  assets  for  impairment  when  facts  and 
circumstances  suggest  that  the  carrying  amount  of  the  asset  may  exceed  its  recoverable 
amount. Any such impairment charges are recognized in profit or loss. 

Once the technical feasibility and commercial viability of extracting the resource has been 
determined and management plans to develop the property, the property will be considered 
a  mine  under  development  and  will  be  classified  as  “mines  under  construction”  in  the 
consolidated  statement  of  financial  position.    As  part  of  the  reclassification,  “mines  under 
construction” will be tested for impairment. 

Page | 17 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.6  

Rehabilitation provisions

The  Company  recognizes  provisions  for  statutory,  contractual,  constructive  or  legal 
obligations, including those associated with the reclamation of environmental disturbances 
caused  by  exploration  and  evaluation  activities.  The  nature  of  the  rehabilitation  activities 
includes restoration, reclamation and re-vegetation of the affected exploration sites.  Initially, 
a provision for a decommissioning liability is recognized as its present value in the period in 
which it is incurred. Upon initial recognition of the liability, a corresponding amount is added 
to the carrying amount of the related asset and the cost is amortized as an expense over the 
economic  life  of  the  asset  using  either  the  unit-of-production  method  or  the  straight-line 
method, as appropriate. Following the initial recognition of the decommissioning liability, the 
carrying amount of the liability is increased for the passage of time and adjusted for changes 
to the current market-based discount rate and the amount or timing of the underlying cash 
flows needed to settle the obligation. 
Taxation 

3.7 

Income tax expense represents the sum of current and deferred income tax. 
Current income tax 

Current  income  tax  assets  and  liabilities  are  measured  at  the  amount  expected  to  be 
recovered from or paid to taxation authorities.  The tax rates and tax laws used to compute 
current income taxes for each jurisdiction in which the Company operates, are those that are 
substantively enacted at the end of each reporting period. The Company incurred no current 
income taxes for the years ended December 31, 2019 and 2018. 
Deferred income tax 

Deferred  income  tax  is  provided  for  using  the  liability  method  on  temporary  differences 
between  the  tax  bases  of  assets  and  liabilities  and  their  carrying  amounts  for  financial 
reporting purposes. 

Page | 18 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.7 

Taxation (Continued) 

Deferred income tax (Continued) 

Deferred income tax liabilities are recognized for all taxable temporary differences, except: 
• 

• 

Where the deferred income tax liability arises from the initial recognition of goodwill or 
of an asset or liability in a transaction that is not a business combination and, at the time 
of the transaction, affects neither the accounting profit nor taxable profit or loss; and 
In respect of taxable temporary differences associated with investments in subsidiaries, 
associates  and  joint  ventures,  where  the  timing  of  the  reversal  of  the  temporary 
differences can be controlled by the parent, investor or venturer and it is probable that 
the temporary differences will not reverse in the foreseeable future. 

Deferred  income  tax  assets  are  recognized  for  all  deductible  temporary  differences,  carry 
forward of  unused  tax credits  and  tax  losses,  to  the  extent  that it  is  probable  that  taxable 
profit  will  be  available  against  which  the  deductible  temporary  differences  and  the  carry 
forward of unused tax credits and tax losses can be utilized except: 
• 

• 

Where  the  deferred  income  tax  asset  relating  to  the  deductible  temporary  difference 
arises  from  the  initial  recognition  of  an  asset  or  liability  in  a  transaction  that  is  not  a 
business combination and, at the time of the transaction, affects neither the accounting 
profit nor taxable profit or loss; and 
In  respect  of  deductible  temporary  differences  associated  with  investments  in 
subsidiaries,  associates  and  joint  ventures,  deferred  income  tax  assets  are  recognized 
only to the extent that it is probable that the temporary differences will reverse in the 
foreseeable  future  and  taxable  profit  will  be  available  against  which  the  temporary 
differences can be utilized. 

The carrying amount of deferred income tax assets is reviewed at the end of each reporting 
period and reduced to the extent that it is no longer probable that sufficient taxable profit 
will be available to allow all or part of the deferred income tax asset to be utilized.   

Unrecognized deferred income tax assets are reassessed at the end of each reporting period 
and are recognized to the extent that it has become probable that future taxable profit will 
allow the deferred tax asset to be recovered. Deferred income tax assets and liabilities are 
measured at the tax rates that are expected to apply to the year when the asset is realized or 
the liability is settled, based on tax rates and tax laws that have been substantively enacted 
at the end of each reporting period. 

Page | 19 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.7 

Taxation (Continued) 

Deferred income tax (Continued) 

In  consolidated  financial statements,  temporary  differences  are  determined  by  comparing 
the carrying amounts of assets and liabilities in the consolidated financial statements with 
the appropriate tax base. The tax base is determined by reference to the tax returns of each 
entity in the group. 

Deferred income tax relating to items recognized directly in equity or other comprehensive 
income  or  loss  are  recognized  in  equity  and  not  in  profit  or  loss  or  other  comprehensive 
income or loss. 

Deferred  income  tax  assets  and  deferred  income  tax  liabilities  are  offset  if,  and  only  if,  a 
legally enforceable right exists to set off current tax assets against current tax liabilities and 
the  deferred  tax  assets  and  liabilities  relate  to  income  taxes  levied  by  the  same  taxation 
authority on either the same taxable entity or different taxable entities which intend to either 
settle current tax liabilities and assets on a net basis, or to realize the assets and settle the 
liabilities simultaneously, in each future period in which significant amounts of deferred tax 
assets or liabilities are expected to be settled or recovered. 
Financial Instruments 

3.8 

Classification  

The  Company  classifies  its  financial  instruments  in  the  following  categories:  at  fair  value 
through profit and loss (“FVTPL”), at fair value through other comprehensive income (loss) 
(“FVTOCI”)  or  at  amortized  cost.  The  Company  determines  the  classification  of  financial 
assets at initial recognition. The classification of debt instruments is driven by the Company’s 
business  model  for  managing  the  financial  assets  and  their  contractual  cash  flow 
characteristics. Equity instruments that are held for trading are classified as FVTPL. For other 
equity instruments, on the day of acquisition the Company can make an irrevocable election 
(on an instrument-by-instrument basis) to designate them as FVTOCI. Financial liabilities are 
measured  at  amortized  cost,  unless  they  are  required  to  be  measured  at  FVTPL  (such  as 
instruments held for trading or derivatives) or the Company has opted to measure them at 
FVTPL.  

Page | 20 

 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.8 

Financial Instruments (Continued) 

Measurement  

Financial assets and liabilities at amortized cost 
Financial assets and liabilities at amortized cost are initially recognized at fair value plus or 
minus transaction costs, respectively, and subsequently carried at amortized cost less any 
impairment.  

Financial assets and liabilities at FVTPL 
Financial  assets  and  liabilities  carried  at  FVTPL  are  initially  recorded  at  fair  value  and 
transaction costs are expensed in the consolidated statements of profit or loss. Realized and 
unrealized gains and losses arising from changes in the fair value of the financial assets and 
liabilities held at FVTPL are included in the consolidated statements of profit or loss in the 
period in which they arise. Where management has opted to recognize a financial liability at 
FVTPL,  any  changes  associated  with  the  Company’s  own  credit  risk  will  be  recognized  in 
other comprehensive income or loss.  

Financial assets at FVTOCI 
Financial assets, such as investments in equity instruments, classified at FVTOCI are initially 
recognized at fair value plus transaction costs. Subsequently they are measured at fair value, 
with gains and losses recognized in other comprehensive income or loss.  
Derivative financial instruments  

3.9 

The Company may issue or hold compound financial instruments with embedded derivatives. 
An embedded derivative is separated from its host contract and accounted for as a derivative 
only when three criteria are satisfied: 
• 

• 

• 

When the economic risks and characteristics of the embedded derivative are not closely 
related to those of the host contract;  
A separate instrument with the same terms as the embedded derivative would meet the 
definition of a derivative; and 
The entire instrument is not measured at fair value with changes in fair value recognized 
in the consolidated statements of profit or loss and other comprehensive income or loss. 

Financial assets 

The Company designates financial assets with embedded derivatives as FVTPL on the initial 
recognition and accordingly does not bifurcate between the host contract and the embedded 
derivative.  The  embedded  derivative  is  measured  at  each  reporting  period  using  an 
appropriate valuation model with changes in the fair value being recognized immediately in 
profit or loss.   

Page | 21 

 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.9 

Derivative financial instruments (Continued) 

Financial liabilities 

The Company designates certain financial liabilities with embedded derivatives as FVTPL on 
the initial recognition and accordingly does not bifurcate between the host contract and the 
embedded  derivative.    However,  other  financial  liabilities  with  embedded  derivatives  are 
bifurcated depending on the instrument. In the case of the latter, the debt host component is 
classified as other financial liabilities and is measured at amortized cost using the effective 
interest rate method.  The embedded derivatives are classified as FVTPL and all changes in 
fair value are recorded in profit or loss.  The difference between the debt host component and 
the principal amount of the loan outstanding is recorded as profit or loss over the expected 
life of the financial liabilities. 
Impairment of financial assets 

3.10 

Assets carried at amortized cost  

At  the  end  of  each  reporting  period,  the  Company  assesses  whether  a  financial  asset  is 
impaired. 

If there is objective evidence that an impairment loss has been incurred, the amount of the 
loss is measured as the difference between the asset’s carrying amount and the present value 
of estimated future cash flows discounted at the financial asset’s original effective interest 
rate. The carrying amount of the asset is then reduced by the amount of the impairment and 
the amount of the loss is recognized in profit or loss.  

If, in a subsequent period, the amount of the impairment loss decreases and the decrease can 
be  related  objectively  to  an  event  occurring  after  the  impairment  was  recognized,  the 
previously recognized impairment loss is reversed to the extent that the carrying value of the 
asset does not exceed what the amortized cost would have been had the impairment not been 
recognized. Any subsequent reversal of an impairment loss is recognized in profit or loss. 
Impairment of non-financial assets 

3.11 

At the end of each reporting period, the Company reviews the carrying amounts of its tangible 
and  intangible  assets  to  determine  whether  there  is  an  indication  that  those  assets  have 
suffered an impairment loss.  If any such indication exists, the recoverable amount of the asset 
is estimated in order to determine the extent of the impairment loss, if any.  Where it is not 
possible to estimate the recoverable amount of an individual asset, the Company estimates 
the recoverable amount of the cash-generating unit to which the assets belong. 

Page | 22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.11 

Impairment of non-financial assets (Continued) 

The  recoverable  amount  is  the  higher  of  fair  value  less  costs  to  sell  and  value  in  use.    In 
assessing fair value less costs to sell, recent market transactions are taken into account.  The 
Company  also  considers  the  results  of  an  appropriate  valuation  model,  which  would 
generally be determined based on the present value of estimated future cash flows arising 
from  the  continued  use  and  eventual  disposal  of  the  asset.    In  assessing  value  in  use,  the 
estimated future cash flows are discounted to their present value using a pre-tax discount 
rate that reflects the current market and the risks specific to the asset. 

If the recoverable amount of an asset or cash-generating unit is estimated to be less than its 
carrying  amount,  the  carrying  amount  is  reduced  to  its  recoverable  amount  and  the 
impairment loss is recognized in profit or loss.  

Where an impairment loss subsequently reverses, the carrying amount is increased to the 
revised estimate of its recoverable amount, but not above the original carrying amount. 
Derecognition of financial assets and financial liabilities  

3.12

Financial assets are derecognized when the rights to receive cash flows from the assets expire 
or  the  Company  has  transferred  substantially  all  the  risks and  rewards  of ownership.    On 
derecognition,  the  difference  between  the  asset’s  carrying  amount  and  the  sum  of  the 
consideration  received  and  receivable  and  the  cumulative  gain  or  loss  that  had  been 
recognized directly in equity is recognized in profit or loss. 

Financial liabilities are derecognized when the obligation specified in the underlying contract 
is  discharged,  cancelled  or  expired.  The  difference  between  the  carrying  amount  of  the 
financial liability derecognized and the consideration paid and payable is recognized in profit 
or loss, unless the financial liability is settled with the Company’s shares, in which case it is 
recognized in profit or loss or equity. 

3.13  Common shares 

Common shares are classified as equity. Costs directly attributable to the issuance of common 
shares are shown in equity as a reduction, net of tax, of the proceeds. 
Share purchase warrants 

3.14 

Share purchase warrants are considered a derivative liability, as the currency denomination 
of the exercise price is different from the functional currency of the Company. As a result, the 
fair value of the share purchase warrants are calculated on the issuance date using the Black-
Scholes option pricing model. Any foreign exchange or change in the fair value of the warrant 
subsequent to the initial recognition is recorded in profit or loss. 

Page | 23 

 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.15 

Share-based compensation 

Where equity-settled share options are granted to employees, inclusive of directors of the 
Company, the fair value of the options granted is measured using the Black-Scholes option 
pricing model and is charged to the statement of profit or loss or capitalized to exploration 
and evaluation assets over the vesting period.  An individual is classified as an employee when 
the  individual  is  an  employee  for  legal  or  tax  purposes  (a  “direct  employee”)  or  provides 
services similar to those performed by a direct employee.  Certain employees of the Company 
receive a portion of their remuneration in the form of share-based payments. 

Where equity-settled share options are granted to non-employees, they are measured at the 
fair value of the goods or services received. However, if the value of goods or services received 
in exchange for the options cannot be reliably estimated, the options are measured using the 
Black-Scholes option pricing model. 

All  equity-settled  share-based  compensation  is  reflected  in  share  option  reserve,  until 
exercised.  Upon exercise, shares are issued from treasury and the amount reflected in share 
option reserve is credited to common shares, together with any consideration received. 

3.16  Loss per share 

Basic loss per share is calculated by dividing the net loss attributable to equity holders of the 
Company by the weighted average number of shares outstanding during the reporting period.  

Diluted loss per share is calculated by adjusting the net loss attributable to equity holders of 
the Company and the weighted average number of shares outstanding for the effects of all 
dilutive share equivalents. The Company’s dilutive share equivalents include stock options, 
share purchase warrants and convertible securities. 

In the Company’s case, diluted loss per share is the same as basic loss per share, as the effect 
of outstanding share options on loss per share would be anti-dilutive. 

3.17  Related party transactions 

Parties are considered related if one party has the ability, directly or indirectly, to control the 
other  party  or  exercise  significant  influence  over  the  other  party  in  making  financial  and 
operating  decisions.    Parties  are  also  considered  related  if  they  are  subject  to  common 
control. Related parties may be individuals or corporate entities.  A transaction is considered 
to be a related party transaction when there is a transfer of resources or obligations between 
related parties.  

Page | 24 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
3. 

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 

3.18 

Segment reporting 

Operating segments are reported in a manner consistent with the internal reporting provided 
to  the  chief  operating  decision-maker.  The  chief  operating  decision-maker,  who  is 
responsible for allocating resources and assessing performance of the operating segments, 
has been identified as the executive management that makes strategic decisions. 

3.19  Adoption of new standards, interpretations and amendments 

Leases

The Company adopted the requirements of IFRS 16 – 
 (“IFRS 16”) as of January 1, 2019.  
IFRS 16 applies a control model to the identification of leases, distinguishing between a lease 
and a service contract on the basis of whether the customer controls the leased asset. For 
assets  that  meet  the  definition  of  a  lease,  IFRS  16  requires  a  single,  on-balance  sheet 
accounting model similar to finance lease accounting, with exceptions for short-term leases, 
leases of low value assets, and mineral exploration leases.  Accordingly, IFRS 16 applies only 
to  the  Company’s  office  leases.    The  Company  has  applied  the  modified  retrospective 
approach in adopting IFRS 16. 

On  January  1,  2019  the  Company  recorded  right-of-use  assets  totaling  $152,214  with  a 
corresponding  entry  to  operating  lease  obligations.    The  Company  calculated  the  present 
value of the minimum lease payments using an incremental borrowing rate of 7% and an 
exchange  rate  of  $/C$  1.3642.      Thereafter,  the  right-of-use  assets  are  depreciated  on  a 
straight-line basis over the term of the leases, which range from 2 to 5 years. 

During the year ended December 31, 2019, the Company recorded interest expense of $9,734, 
accretion of $46,489,  and depreciation of $40,857. 
Standards issued but not yet effective  

3.20 

A  number  of  new  standards,  amendments  to  standards  and  interpretations  are  not  yet 
effective as of December 31, 2019 and have not been applied in preparing these consolidated 
financial statements.  These standards are not expected to materially impact the Company’s 
financial position or results of operations. 

Page | 25 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
4. 

SEGMENTED INFORMATION 

The  Company  had  two  reportable  business  segments  being  the  United  States  Uranium 
Division  and  the  Kyrgyzstan  Uranium  Division.  The  Company’s  chief  operating  decision 
maker  reviews  both  business  segments’  discrete  financial  information  to  make  decisions 
about resources to be allocated to each segment and to assess their performance. 

The  carrying  amount  of  the  Company’s  assets,  liabilities  and  exploration  and  evaluation 
assets  and  the  Company’s  loss  before  income  tax  and  impairment  of  exploration  and 
evaluation assets analyzed by operating segment are as follows: 
Kyrgyzstan 
Uranium 
Division *

United States 
Uranium 
Division

Unallocated 
**

Consolidated 
Total

Segment assets

As at December 31, 2019
As at December 31, 2018

Segment liabilities

$  
$  

41,614,854
42,730,212

$                   
-
$     

4,389,464

$          
$          

235,772
184,677

$   
$   

41,850,626
47,304,353

As at December 31, 2019
As at December 31, 2018

Exploration and evaluation assets (Note 6)

$    
$    

3,529,037
3,589,458

$                   
-
$     

1,633,878

$      
$          

1,079,058
933,635

$      
$      

4,608,095
6,156,971

As at December 31, 2019
As at December 31, 2018
Net loss before income tax

$  
$  

41,440,616
42,471,383

$                   
-
$     

4,225,090

$                    
-
$                    
-

$   
$   

41,440,616
46,696,473

Year ended December 31, 2019
Year ended December 31, 2018

$  
$      

(2,625,178)
(443,236)

$   
$       

(3,763,180)
(117,560)

$    
$    

(1,471,638)
(1,666,929)

$    
$    

(7,859,996)
(2,227,725)

Impairment of exploration and evaluation assets (Note 6)

Year ended December 31, 2019
Year ended December 31, 2018

(2,422,398)

$  
$                  
-

(4,140,444)

$   
$                   
-

$                    
-
$                    
-

(6,562,842)

$    
$                    
-

* the Company sold the Kyrgyzstan Uranium Division in October 2019, See Note 6. 
**  the  unallocated  amount  contains  all  amounts  associated  with  the  corporate 
division. 

Page | 26 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
5. 

ACQUISITION OF URZ ENERGY 

On July 5, 2018, the Company completed the acquisition of URZ Energy through the issue of 
57,920,716  common  shares  of  the  Company  valued  at  $11,237,756.  Each  URZ  Energy 
shareholder  received  two  Azarga  Uranium  shares  for  each  URZ  Energy  share  held  (the 
“Exchange Ratio”). 

All outstanding share purchase warrants and stock options of URZ Energy were adjusted in 
accordance with their terms and the Exchange Ratio such that Azarga Uranium reserved for 
issue: 
• 

• 

• 

14,806,700 share purchase warrants with an exercise price of C$0.20 expiring August 15, 
2018.   The share  purchase  warrants  were  valued at  $644,530 using  the  Black-Scholes 
option pricing model with the following assumptions: a risk-free interest rate of 1.90%; 
an expected volatility of 55.1%; an expected life of 0.11 years; a forfeiture rate of zero; an 
expected dividend of zero; and an exchange rate of 1.3143; 
2,304,184 share purchase warrants with an exercise price of C$0.375 expiring June 19, 
2019.    The  share  purchase  warrants  were  valued  at  $41,784  using  the  Black-Scholes 
option pricing model with the following assumptions: a risk-free interest rate of 1.90%; 
an expected volatility of 55.1%; an expected life of 0.96 years; a forfeiture rate of zero; an 
expected dividend of zero; and an exchange rate of 1.3143; and 
4,480,000 stock options with an exercise price of C$0.075 expiring March 14, 2027. The 
stock options were valued at $769,169 using the Black-Scholes option pricing model with 
the  following  assumptions:  a  risk-free  interest  rate  of  2.12%;  an  expected volatility  of 
76.5%; an expected life of 8.7 years; a forfeiture rate of zero; an expected dividend of zero; 
and an exchange rate of 1.3143. 

The Company paid transaction costs of $146,601 in cash and issued 186,393 common shares 
of the Company valued at $36,164. 

URZ Energy, a British Columbia Corporation, owns all the issued and outstanding shares of 
Ucolo  Exploration  Corp.  (“Ucolo”),  a  Utah  Corporation.    As  discussed  further  in  Note  6,  at 
acquisition, Ucolo held certain uranium projects located in Wyoming, Colorado and Utah. 

Page | 27 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
5. 

ACQUISITION OF URZ ENERGY (Continued) 

Consideration

Shares issued
Warrants issued
Options issued
Transaction costs - shares
Transaction costs - cash
Due from Azarga Uranium *
Total

Net assets received

Cash
Other assets
Exploration and evaluation assets
Property, plant and equipment
Reclamation bonds
Trade and other payables
Decommissioning liabilities
Total

$        

$        

11,237,756
686,314
769,169
36,164
146,601
(468,567)
12,407,437

$              

570,525
49,192
12,167,005
2,894
97,000
(417,035)
(62,144)
12,407,437

$        

 *  In  May  2018,  URZ  Energy  advanced  $465,000  to  the  Company,  see  Note  7.2.    The  loan 
accrued interest at 5% through completion of the acquisition.  All principal and interest was 
settled on completion of the acquisition. 

Page | 28 

 
 
 
 
 
 
                 
                 
                   
                 
               
                   
          
                      
                   
               
                 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
6. 

EXPLORATION AND EVALUATION ASSETS 

South 
Dakota
Dewey 
Burdock

Gas Hills

Wyoming

Juniper 
Ridge

Colorado

Utah

Other

Centennial

JB

Ticaboo

Kyrgyz 
Republic
Kyzyl
 Ompul

Total

Balance, December 31, 2018
Salaries and consulting 
License fees
Decommissioning liabilities
Share-based compensation
Depreciation
Option payments received
Recoveries
Currency translation effect
Impairment
Balance, December 31, 2019

$ 

26,908,029
468,525
342,758
-
31,676
-
-
-
-
-

$ 

27,750,988
South 
Dakota
Dewey 
Burdock

$       

$       

$    

8,634,378
78,819
104,756
12,308
2,180
-
-
-
-
-

$    

2,747,392
50,743
23,370
-
872
-
-
-
-
-

$       

911,128
43,504
140,762
-
2,617
-
-
-
-
-

$    

2,379,738
21,000
6,000
11,607
4,053
-
-
-
-

(2,422,398)

$    

8,832,441

$    

2,822,377

$    

1,098,011

$                 
-

427,716
7,000
11,006
-
872
-
-
-
-
-
446,594

$       

$       

463,002
12,833
5,898
8,292
2,180
-
-
(2,000)
-
-
490,205

Gas Hills

Wyoming

Juniper 
Ridge

Colorado

Utah

Other

Centennial

JB

Ticaboo

Balance, December 31, 2017
Acquisition of URZ Energy
Acquisition costs
Salaries and consulting 
License fees
Decommissioning liabilities
Share-based compensation
Depreciation
Repurchase of royalties
Option payments received
Recoveries
Currency translation effect
Balance, December 31, 2018

$ 

25,909,535

$                 
-

$                 
-

-
31,250
652,800
276,072
-
18,981
-
19,391
-
-
-

8,512,595

2,724,761

-
21,097
97,525
1,806
1,355
-
-
-
-
-

-
1,580
20,509
-
542
-
-
-
-
-

$ 

26,908,029

$    

8,634,378

$    

2,747,392

$       

$       

692,775
63,645
-
25,427
127,653
-
1,628
-
-
-
-
-
911,128

$    

2,332,215

-
-
28,000
2,530
14,281
2,712
-
-
-
-
-

$    

2,379,738

-
$                 
415,467
-
1,400
10,307
-
542
-
-
-
-
-
427,716

$       

-
$                 
450,537
-
3,500
5,317
2,293
1,355
-
-
-
-
-
463,002

$       

$    

4,225,090
17,940
67,810
-
12,111
2,943
(130,000)
(25,779)
(29,671)
(4,140,444)

$                 
-
Kyrgyz 
Republic
Kyzyl
 Ompul

$    

4,069,145

-
-
46,409
468,918
-
10,187
5,930
-
(290,000)
(68,697)
(16,802)
4,225,090

$    

$ 

46,696,473
700,364
702,360
32,207
56,561
2,943
(130,000)
(27,779)
(29,671)
(6,562,842)
41,440,616

Total

$ 

$ 

33,003,670
12,167,005
31,250
780,213
1,008,831
18,380
37,302
5,930
19,391
(290,000)
(68,697)
(16,802)
46,696,473

$ 

Page | 29 

 
 
 
 
 
 
          
             
             
             
             
               
             
             
          
          
          
             
          
               
             
               
             
          
                    
             
                    
                    
             
                    
               
                    
             
             
               
                   
               
               
                   
               
             
             
                    
                    
                    
                    
                    
                    
                    
               
               
                    
                    
                    
                    
                    
                    
                    
        
        
                    
                    
                    
                    
                    
                    
             
           
           
                    
                    
                    
                    
                    
                    
                    
           
           
                    
                    
                    
                    
    
                    
                    
    
    
                    
      
      
             
                    
          
          
                    
    
             
                    
                    
                    
                    
                    
                    
                    
             
          
             
               
             
             
               
               
             
          
          
             
             
          
               
             
               
          
      
                    
               
                    
                    
             
                    
               
                    
             
             
               
                   
               
               
                   
               
             
             
                    
                    
                    
                    
                    
                    
                    
               
               
             
                    
                    
                    
                    
                    
                    
                    
             
                    
                    
                    
                    
                    
                    
                    
        
        
                    
                    
                    
                    
                    
                    
                    
           
           
                    
                    
                    
                    
                    
                    
                    
           
           
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
6. 

EXPLORATION AND EVALUATION ASSETS (Continued) 

6.1 

Dewey Burdock Project, South Dakota 

The Dewey Burdock Uranium Project is an in-situ recovery uranium project located in the 
Edgemont  uranium  district  in  South  Dakota.  The  Dewey  Burdock  Uranium  Project  is  the 
Company’s initial development priority. 

In 2006, the Company entered into an option agreement to purchase mineral rights on certain 
areas of the Dewey Burdock Project for consideration of $200,000 plus contingent payments 
of  $750,000  payable  in  four  equal  instalments  of  $187,500  commencing  12  months 
subsequent to the receipt of all regulatory permits and licenses allowing uranium production 
on the area of the Dewey Burdock Project pertaining to these mineral interests.  The Company 
has disclosed these contingent amounts as a commitment in Note 18. 

In 2008, the Company entered into an option agreement to purchase mineral rights on certain 
areas of the Dewey Burdock Project for consideration of $600,000 plus contingent payments 
of  $1,300,000.    On  October  31,  2018,  the  Company  entered  into  an  amending  agreement 
whereby the $1,300,000 contingent payments are payable as follows:  $31,250 on signing the 
amending agreement; nine payments of $31,250 payable each May 31 and October 1; and ten 
payments of $98,750 payable thereafter each May 31 and October 1 with the final payment 
of $98,750 being made on May 31, 2028.  If the Company receives all regulatory permits and 
licenses allowing uranium production on the area of the Dewey Burdock Project pertaining 
to  these  mineral  interests  before  completion  of  the  aforementioned  payments,  then  the 
balance of payments owing shall be payable in four equal installments annually beginning 
one year from that date with a minimum payment of $98,750 a year until paid in full.  The 
Company has disclosed these contingent amounts as a commitment in Note 18. 

On  December  7,  2017,  the  Company  entered  into  an  agreement  to  repurchase  royalties 
related to uranium production on certain areas of the Dewey Burdock project for C$25,000 
which  was  settled  on  March  23,  2018  by  the  issue  of  104,166  common  shares  valued  at 
$19,391, see Note 10.2. 

Page | 30 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
6. 

EXPLORATION AND EVALUATION ASSETS (Continued) 

6.2  

Centennial Project, Colorado 

The Centennial Uranium Project is located in the western part of Weld County in northeastern 
Colorado. 

In 2006, the Company entered into an option agreement, as amended, to purchase uranium 
rights  on  certain  areas  of  the  Centennial  Project  for  consideration  of  $1,895,000  plus 
contingent payments of $3,165,000. Pursuant to the agreement, the contingent payments are 
payable upon receipt of regulatory permits and licenses allowing uranium production on the 
area  of  the  Centennial  Project  pertaining  to  these  uranium  interests.    Further,  unless 
otherwise agreed, if the Company does not obtain such permits and licenses by September 
27, 2019, the uranium rights, at the option of the seller, can be transferred back to the seller.  
To date, the Company has neither obtained the required regulatory permits and licenses nor 
has the Company been able to renegotiate the option agreement.  However, the Company is 
attempting to renegotiate the option agreement and the seller has not exercised its option to 
have the uranium rights transferred back. 

As a result of the uncertainty surrounding this option agreement, which represents 5,760 of 
the  6,238  mineral  acres  at  the  Centennial  Project,  significant  doubt  over  the  future 
recoverability of the carrying value exists.  Accordingly, during the year ended December 31, 
2019,  the  Company  recognized  an  impairment  charge  of  $2,422,398  for  the  Centennial 
Project. 

The Company has disclosed the contingent amount of $3,165,000 as a commitment in Note 
18. 
URZ Energy uranium projects 

6.3 

In July 2018, the Company acquired URZ Energy and the Gas Hills, Juniper Ridge and Shirley 
Basin  uranium  projects  in  Wyoming,  the  JB  uranium  project  in  Colorado  and  the  Ticaboo 
uranium project in Utah, See Note 5. 

Page | 31 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
6. 

EXPLORATION AND EVALUATION ASSETS (Continued) 

6.4 

Kyzyl Ompul Project, Kyrgyz Republic  

In  October  2019,  the  Company  sold  its  interest  in  UrAsia  in  Kyrgyzstan  Limited  Liability 
Company  (“UrAsia”)  to  Central  Asian  Uranium  Company  Limited  Liability  Company 
(“Central”).  UrAsia held a 100% interest in the Kyzyl Ompul Project. 

In  April  2018,  as  amended,  UrAsia  entered  into  an  earn-in  agreement  (the  “Earn-in 
Agreement”) with Central pursuant to which Central had an option to earn a 100% interest 
in the Kyzyl Ompul Project in exchange for $5,850,000 in cash payments and a commitment 
to fund $1,500,000 of exploration and development expenditures through December 1, 2020.  
During  the  year  ended  December  31,  2019  and  2018,  Central  made  cash  payments  of 
$130,000 and $290,000, respectively, to the Company under the Earn-in Agreement. 

In May 2019, the Kyrgyz Republic’s parliament voted to ban uranium exploration and mining 
in the country.  The Kyzyl Ompul Project exploration license was subsequently suspended 
due  to  force  majeure  circumstances,  among  other  reasons,  resulting  from  the  Kyrgyz 
Republic government’s actions.  The Company determined that these events in the Kyrgyz 
Republic cast significant doubt over the future validity of the Company’s exploration license 
on the Kyzyl Ompul Project as well as on the future cash flows expected under the Earn-in 
Agreement.  Accordingly, during the year ended December 31, 2019, the Company recognized 
an impairment charge of $4,140,444 for the Kyzyl Ompul Project. 

Page | 32 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
6. 

EXPLORATION AND EVALUATION ASSETS (Continued) 

6.4 

Kyzyl Ompul Project, Kyrgyz Republic (Continued) 

In  October  2019,  the  Company  sold its  93.1%  interest  in UrAsia  for  cash  consideration  of 
$232,750.  In addition, UrAsia granted the Company a 1.862% net smelter return royalty on 
any future uranium production from the Kyzyl Ompul Project up to $4,655,000. 
Consideration received

Cash *
NSR royalty **
Total
Net assets (liabilities) sold

Cash
Restricted cash
Exploration and evaluation assets ***
Property, plant and equipment
Trade and other payables
Total
Gain on sale of UrAsia

$              

$              

192,250
-
192,250

$                       

841
17,314
-
13,091
(338,169)
(306,923)

$            

$              

499,173

* the cash consideration has been grossed up to 100% and adjusted for the cash consideration 
of $57,750 not received to date  
** the Company did not assign a value to the 1.862% net smelter return royalty due to the 
uncertainty over its realization. 
*** As described above, the Company recognized a full impairment charge of the Kyzyl Ompul 
Project  prior  to  the  sale  of  UrAsia.    Accordingly,  the  net  book  value  of  exploration  and 
evaluation assets at the time of sale was $Nil. 

Page | 33 

 
 
 
 
 
 
 
 
 
 
 
                           
                   
                           
                   
               
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
7. 

LOANS PAYABLE 

7.1 

Loan payable to shareholders 

On  July  31,  2012,  the  Company  entered  into  a  convertible  loan  agreement  with  certain 
shareholders  of  the  Company  for  $1,776,000  (the  “Shareholders’  Loan”).    Pursuant  to  the 
agreement, as amended, the Shareholders’ Loan accrued interest at 15% per annum payable 
on  each  anniversary  of  the  agreement,  was  unsecured,  was  convertible  into  shares  of  the 
Company  at  the  shareholders’  option  at  C$1.23,  and  matured  July  31,  2020.    The  annual 
interest that was due on July 31, 2017 was deferred until July 31, 2018.  During the year ended 
December 31, 2018, the Company recorded interest expense of $143,219. 

In  July  2018,  the  Company  issued  11,269,243  common  shares  of  the  Company  valued  at 
$2,201,024  in  full  and  final  settlement  of  the  Shareholders’  Loan,  including  principal  of 
$1,776,000 and accrued interest to the date of settlement of $425,024. 

7.2        URZ Energy Loan 

In May 2018, URZ Energy advanced $465,000 to the Company.  The loan accrued interest at 
5%  through  completion  of  the  acquisition  of  URZ  Energy.    All  principal  and  interest  was 
thereafter  settled  on  completion  of  the  acquisition.    During  the  year  ended  December  31, 
2018, the Company recorded interest expense of $3,567. 

7.3        Other loans payable 

As at December 31, 2017, the Company had other loans outstanding of $46,873.  During the 
year  ended  December  31,  2018,  the  Company  received  $50,000  from  a  third  party  and 
recorded interest expense of $8,127 on other loans.  During the year ended December 31, 
2018, principal and interest totaling $105,000 was repaid in full. 

Page | 34 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
8. 

DECOMMISSIONING LIABILITIES 

Year ended December 31,
2019
2018

Balance, beginning of year
Assumed on acquisition of URZ Energy
Additions
Accretion
Balance, end of year

$                      

$                      

223,442
-
-
28,108
251,550

142,918
62,144
1,281
17,099
223,442

$                      

$                      

Decommissioning liabilities include the net present value of the estimated cost of reclaiming 
exploration  ground  on  the  Company’s  Centennial,  Gas  Hills  and  Ticaboo  projects.    The 
Company  has  no  material  restoration,  rehabilitation  and  environmental  obligations  on  its 
other  uranium  projects  as  environmental  disturbance  to  date  has  been  minimal  or 
reclamation has been completed. 

The Company assumed reclamation bonds on acquisition of URZ Energy of $63,000 for Gas 
Hills  and $34,000  for  Ticaboo.    These  reclamation  bonds,  along  with  an  additional  $2,000 
bond posted in 2018, were recorded on the consolidated statement of financial position as at 
December 31, 2018, until surety bond financing was obtained in 2019. 

9.   WARRANT LIABILITIES 

Year ended December 31,
2019
2018

Balance, beginning of year
Issuance of warrants - private placements
Un realized gain on revaluation
Currency translation effect
Balance, end of year

$                      

$                      

247,654
378,506
(371,983)
10,852
265,029

258,116
68,055
(51,789)
(26,728)
247,654

$                      

$                      

Share purchase warrants are considered a derivative liability, as the currency denomination 
of the exercise price is different from the functional currency of the Company.  

Warrant liabilities were revalued as at December 31, 2019 and 2018 using the Black-Scholes 
option pricing model with the following assumptions: a risk free interest rate of 1.68% (2018 
– 1.85%); an expected volatility of 61.8% (2018 – 58.4%); an expected life of 1-3 years (2018 
– 1-3 years); a forfeiture rate of zero (2018 – zero); an expected dividend of zero (2018 – 
zero); and an exchange rate of 1.2988 (2018 – 1.3642). 

Page | 35 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                   
                           
                                   
                              
                           
                           
                         
                           
                       
                         
                           
                         
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
10.   EQUITY 

10.1  Authorized share capital 

The Company has authorized the issuance of an unlimited number of common and preferred 
shares with no par value.  As at December 31, 2019 and 2018, the Company had 185,543,926 
and  169,833,806 common  shares outstanding, respectively,  and  no  preferred  shares  were 
outstanding.  
Issued share capital 

10.2 

During  the  year  ended  December  31,  2019,  the  Company  completed  the  following  equity 
transactions: 

• 

In  March  2019,  the  Company  closed  a  non-brokered  private  placement  for  gross 
proceeds of $2,266,169 (C$3,014,391) through the issuance of 13,106,046 units at a 
price of C$0.23 per unit.  Each unit consists of one common share and one-half of one 
share purchase warrant.  Each whole warrant entitles the holder thereof to purchase 
one common share at a price of C$0.31 per share until March 20, 2022. 

The warrants were valued on a relative fair value basis at $378,506 using the Black-
Scholes option pricing model with the following assumptions: a risk-free interest rate 
of 1.61%; an expected volatility of 63.4%; an expected life of 3 years; a forfeiture rate 
of zero; an expected dividend of zero; and an exchange rate of $/C$ 1.3335. 

The Company paid cash finder’s fees of $5,696 and other share issue costs of $10,857. 

In  July  2019,  the  Company  issued  900,000  common  shares  to  settle  $170,068  of 
outstanding  employee  remuneration.    As  a  result,  $170,068  was  reclassified  from 
contributed surplus to share capital. 

During the year ended December 31, 2019, the Company issued 1,380,521 common 
shares to settle $231,424 owing pursuant to the Company’s employee share purchase 
plan (“ESPP”) and 323,553 common shares to settle $55,001 owing pursuant to the 
Company’s director services agreements (“DSA”). 

• 

• 

During  the  year  ended  December  31,  2018,  the  Company  completed  the  following  equity 
transactions: 

• 

In January 2018, the Company closed the second and final tranche of its non-brokered 
private placement for gross proceeds of $157,366 (C$195,000) through the issuance 
of 780,000 units at a price of C$0.25 per unit.  Each unit consists of one common share 
and one-half of one share purchase warrant.  Each whole warrant entitles the holder 
thereof to purchase one common share at a price of C$0.35 per share until December 
22, 2020. 

Page | 36 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
10.   EQUITY (Continued) 

10.2 

Issued share capital (Continued) 

• 

• 

• 

• 

• 

• 

• 

• 

• 

The warrants were valued on a relative fair value basis at $16,562 using the Black-
Scholes option pricing model with the following assumptions: a risk-free interest rate 
of 1.99%; an expected volatility of 61.1%; an expected life of 3 years; a forfeiture rate 
of zero; an expected dividend of zero; and an exchange rate of 1.2321. 

In  March  2018,  the  Company  issued  186,512  common  shares  to  a  shareholder  in 
settlement of $36,169 (C$46,628) of trade and other payables. 

In  March  2018,  the  Company  issued  104,166  common  shares  valued  at  $19,391 
(C$25,000) to repurchase royalties on the Dewey Burdock Project, see Note 6. 

In June 2018, the Company issued 578,822 common shares to a director valued at 
$108,828 to settle trade and other payables of $187,500 and accordingly recorded a 
gain on settlement of $78,672. 

In  July  2018,  the  Company  issued  550,000  common  shares  to  settle  $93,500  of 
outstanding  employee  remuneration.    As  a  result,  $93,500  was  reclassified  from 
contributed surplus to share capital. 

In July 2018, the Company issued 57,920,716 common shares valued at $11,237,756 
for  the  acquisition  of  URZ  Energy,  see  Note  5.    In  addition,  the  Company  issued 
186,393 common shares valued at $36,164 for transaction costs. 

In July 2018, the Company issued 1,268,000 common shares valued at $246,017 to 
settle  trade  and  other  payables  of  $201,830  and  accordingly  recorded  a  loss  on 
settlement of $44,187. 

In July 2018, the Company issued 11,269,243 common shares valued at $2,201,024 
in full and final settlement of the Shareholders’ Loan, see Note 7.1. 

During the year ended December 31, 2018, the Company issued 11,950,866 common 
shares for gross proceeds of $1,827,078 pursuant to the exercise of share purchase 
warrants. 

During the year ended December 31, 2018, the Company issued 1,115,301 common 
shares  to  settle  $215,344  owing  pursuant  to  the  Company’s  ESPP  and  303,937 
common shares to settle $58,669 owing pursuant to the Company’s DSA. 

Page | 37 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
10.   EQUITY (Continued) 

10.3 

Share purchase warrants 

The  continuity  of  share  purchase  warrants  for  the  year  ended  December  31,  2019  is  as 
follows: 
Expiry date

Balance, 
December 31, 
2019

Balance, 
December 31, 
2018

Exercise
 price
 C$

Exercised

Expired

Issued

June 19, 2019
September 23, 2019
July 27, 2020
December 22, 2020
March 20, 2022

$      
$         
$         
$         
$         

0.375
0.35
0.36
0.35
0.31

2,304,184
4,621,665
2,333,968
1,567,500

-

10,827,317

-
-
-
-

6,553,022
6,553,022

-
-
-
-
-
-

(2,304,184)
(4,621,665)

-
-
-

(6,925,849)

-
-

2,333,968
1,567,500
6,553,022
10,454,490

Weighted average exercise price (C$)

$                  

0.36

$              

0.31

$                      
-

$              

0.36

$                    

0.33

The weighted average remaining contractual life is 1.67 years. 

The  continuity  of  share  purchase  warrants  for  the  year  ended  December  31,  2018  is  as 
follows: 
Expiry date

Balance, 
December 31, 
2017

Balance, 
December 31, 
2018

Exercise
 price
 C$

Exercised

Expired

Issued

September 23, 2019
July 27, 2020
December 22, 2020
August 15, 2018
June 19, 2019

$         
$         
$         
$         
$      

0.35
0.36
0.35
0.20
0.375

4,621,665
1,833,968
677,500
-
-

7,133,133

-
500,000
890,000
14,806,700
2,304,184
18,500,884

-
-
-

-
-
-

(11,950,866)

(2,855,834)

-

-

(11,950,866)

(2,855,834)

4,621,665
2,333,968
1,567,500

-

2,304,184
10,827,317

Weighted average exercise price (C$)

$                  

0.35

$              

0.23

$              

0.20

$              

0.20

$                    

0.36

In  July  2018,  the  Company  issued 1,000,000 share  purchase  warrants  to  an  insider  of  the 
Company as part of two private placements completed in 2017. The Company issued 500,000 
share purchase warrants with an exercise price of C$0.36 and an expiry date of July 27, 2020 
and 500,000 share purchase warrants with an exercise price of C$0.35 and an expiry date of 
December 22, 2020 upon receipt of disinterested shareholder and TSX approval. 

The 1,000,000 warrants were valued at $51,493. The warrants were valued using the Black-
Scholes  option  pricing  model  with  the  following  assumptions:  a  risk  free  interest  rate  of 
1.99%; an expected volatility of 61.09%; an expected life of 2-3 years; a forfeiture rate of zero; 
an expected dividend of zero; and an exchange rate of 1.3143. 

Page | 38 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
                   
                   
   
                         
         
                   
                   
   
                         
         
                   
                   
                   
           
         
                   
                   
                   
           
                       
     
                   
                   
           
       
     
                   
   
         
         
                   
                   
                   
           
         
         
                   
                   
           
             
         
                   
                   
           
                       
   
 
   
                         
                       
     
                   
                   
           
         
   
 
   
         
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
10.   EQUITY (Continued) 

10.4  Equity settled compensation arrangements  

ESPP 

In 2015, the Company adopted an ESPP which was amended in July 2018.  The Company is 
authorized to issue up to 6,000,000 common shares pursuant to the terms and conditions of 
the ESPP. Employees, who elect to participate in the ESPP, can contribute up to 50% of their 
salary  (the  “Employee  Contribution”).    The  Company  will  then  match  66.67%  of  the 
Employee’s Contribution (the “Matching Contribution”).  The purchase price of the common 
shares  is  calculated  based  on  the  five-day  volume  weighted  average  trading  price  of  the 
common  shares  on  the  TSX  immediately  preceding  the  end  of  each  calendar  quarter.  The 
Employee Contribution and the Matching Contribution are expensed in the period in which 
they are incurred with the offsetting amount being recorded in contributed surplus until the 
common shares are issued. 

For the years ended December 31, 2019 and 2018, Employee Contributions totaled $149,701 
and  $124,941,  respectively,  and  Matching  Contributions  totaled  $99,807  and  $83,296, 
respectively.  As at December 31, 2019, a cumulative total of 5,062,690 common shares have 
been issued pursuant to the ESPP.  Subsequent to December 31, 2019, the Company issued 
457,648 common shares pursuant to the ESPP, see Note 22. 
DSA 

In 2015, the Company adopted the DSA.  The Company is authorized to issue up to 2,000,000 
common  shares  pursuant  to  the  terms  and  conditions  of  the  DSA.    Directors  who  elect  to 
participate  in  the  DSA  contribute  50%  of  their  director  fee/salary  to  the  ESPP  and  the 
remaining 50% of their director fee/salary is settled through the issuance of common shares 
in accordance with the DSA.  The purchase price of the common shares is calculated based on 
the  five-day  volume  weighted  average  trading  price  of  the  common  shares  on  the  TSX 
immediately preceding the end of each calendar quarter. Amounts settled in accordance with 
the DSA are expensed in the period in which they are incurred with the offsetting amount 
being recorded in contributed surplus until the common shares are issued.  

For the years ended December 31, 2019 and 2018, $55,001 and $56,277, respectively, were 
expensed under the DSA.  As at December 31, 2019, a cumulative total of 1,556,594 common 
shares had been issued pursuant to the DSA. Subsequent to December 31, 2019, the Company 
issued 87,543 common shares pursuant to the DSA, see Note 22. 

Page | 39 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
11.  

SHARE OPTION RESERVE 

11.1 

Stock option plan 

In July 2018, the Company adopted a new rolling stock option plan, which permits the Board 
of Directors of the Company to grant stock options for up to 10% of the outstanding common 
shares of the Company. The exercise price of an option shall not be less than the discounted 
market price at the time of granting as prescribed by the policies of the TSX.  The maximum 
term of the stock options is ten years from the grant date.  Vesting terms are at the discretion 
of the Board of Directors. 
Stock option continuity 

11.2 

The continuity of stock options for the year ended December 31, 2019 is as follows: 
Expiry date

Expired/ 
Forfeited

Exercised

Issued

Exercise
 price
C$

Balance, 
December 31, 
2018

Balance, 
December 31, 
2019

October 27, 2019
May 19, 2020
May 19, 2021
May 16, 2022
August 22, 2023
May 23, 2024
March 14, 2027

$         
$      
$         
$         
$         
$         
$      

1.20
0.335
0.36
0.32
0.24
0.23
0.075

393,336
1,015,000
1,165,000
2,040,000
3,692,500

-
-
-
-
-

-

2,395,000

4,480,000
12,785,836

-

2,395,000

-
-
-
-
-
-
-
-

(393,336)
(85,000)
(35,000)
(45,000)
-
-
-
(558,336)

-
930,000
1,130,000
1,995,000
3,692,500
2,395,000
4,480,000
14,622,500

Weighted average exercise price (C$)

$                  

0.24

$              

0.23

$                     
-

$              

0.94

$                    

0.21

As at December 31, 2019, 11,795,000 stock options were exercisable. 

The weighted average remaining contractual life is 4.30 years. 

Page | 40 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
                  
                  
      
                         
         
                  
                  
         
               
         
                  
                  
         
           
         
                  
                  
         
           
         
                  
                  
                  
           
                       
     
                  
                  
           
         
                  
                  
                  
           
       
     
                  
      
        
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
11.  

SHARE OPTION RESERVE (Continued) 

11.2 

Stock option continuity (Continued) 

The continuity of stock options for the year ended December 31, 2018 is as follows: 
Expiry date

Expired/ 
Forfeited

Exercised

Issued

Exercise
 price
C$

Balance, 
December 31, 
2017

Balance, 
December 31, 
2018

April 30, 2018
August 6, 2018
November 3, 2018
November 3, 2018
October 27, 2019
May 19, 2020
May 19, 2021
May 16, 2022
March 14, 2027
August 22, 2023

$         
$         
$         
$         
$         
$      
$         
$         
$      
$         

1.20
0.35
1.20
1.50
1.20
0.335
0.36
0.32
0.075
0.24

165,163
1,000,000
15,513
54,750
393,336
1,030,000
1,185,000
2,060,000

-
-

5,903,762

-
-
-
-
-
-
-
-

4,480,000
3,692,500
8,172,500

-
-
-
-
-
-
-
-
-
-
-

(165,163)
(1,000,000)
(15,513)
(54,750)
-
(15,000)
(20,000)
(20,000)
-
-

(1,290,426)

-
-
-
-
393,336
1,015,000
1,165,000
2,040,000
4,480,000
3,692,500
12,785,836

11.3 

Weighted average exercise price (C$)
Share-based compensation 

$                  

0.43

$              

0.15

$                     
-

$              

0.52

$                    

0.24

During the years ended December 31, 2019 and 2018, the Company recognized share-based 
compensation  expense  of  $309,351  and  $303,346,  respectively,  of  which  $252,790  and 
$266,044,  respectively  has  been  allocated  to  administrative  expenses  and  $56,561  and 
$37,302, respectively has been allocated to exploration and evaluation assets. 

In May 2019, the Company granted 2,395,000 stock options to officers, employees, directors 
and other eligible persons at an exercise price of C$0.23 with an expiry date of May 23, 2024. 
The weighted average fair value of the options granted was estimated at C$0.12 per option at 
the grant date using the Black-Scholes option pricing model with the following assumptions: 
a risk-free interest rate of 1.57%; an expected volatility of 62.6%; an expected life of 5 years; 
a forfeiture rate of zero; an expected dividend of zero; and an exchange rate of 1.348.  

In  August  2018,  the  Company  granted  3,692,500  stock  options  to  officers,  employees, 
directors  and  other  eligible  persons  at  an  exercise  price  of  C$0.24  with  an  expiry  date  of 
August 22, 2023.  The weighted average fair value of the options granted was estimated at 
C$0.14 per option at the grant date using the Black-Scholes option pricing model with the 
following assumptions: a risk-free interest rate of 1.53%; an expected volatility of 68.5%; an 
expected  life  of  5  years;  a  forfeiture  rate  of  zero;  an  expected  dividend  of  zero;  and  an 
exchange rate of 1.302. 

Page | 41 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
                  
                  
      
                         
         
                  
                  
   
                         
                
                  
                  
         
                         
                
                  
                  
         
                         
             
                  
                  
                  
               
         
                  
                  
         
           
         
                  
                  
         
           
         
                  
                  
         
           
                       
     
                  
                  
           
                       
     
                  
                  
           
         
     
                  
   
        
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
12.     ADMINISTRATIVE EXPENSES 

Year ended December 31,
2019
2018

Salaries and benefits
Consulting and professional fees
Corporate administration
Depreciation of property, plant and equipment
Depreciation of right-of-use assets
Share-based compensation

13.  

FINANCE COSTS 

$                      

$                      

932,070
394,747
319,118
3,703
40,857
252,790
1,943,285

929,232
399,197
443,411
2,696
-
266,044
2,040,580

$                  

$                  

Note

Year ended December 31,
2019
2018

Interest expense on operating lease
obligations
Interest expense on Shareholders' Loan
Interest expense on URZ Energy Loan
Interest expense on other loans payable

7.1
7.2
7.3

$                           

$                           

9,734
-
-
-
9,734

-
$                                
143,219
3,567
8,127
154,913

$                      

Page | 42 

 
 
 
 
  
 
 
 
  
 
 
 
 
 
                         
                         
                         
                         
                              
                              
                           
                                   
                         
                         
                                   
                         
                                   
                              
                                   
                              
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
14.  DISCONTINUED OPERATIONS 

In October 2019, the Company sold its Kyzyl Ompul project located in Kyrgyzstan, see Note 
6.  The Company’s operations in Kyrgyzstan represented a separate geographical segment 
and accordingly the Company has presented these operations as discontinued operations for 
years ended December 31, 2019 and 2018. 

Year ended December 31,
2019
2018

Administrative expenses
Foreign exchange loss
Reversal of deferred income tax liabilities on 
impairment of exploration and evaluation assets
Impairment of exploration and evaluation assets
Gain on sale of UrAsia
Net loss from discontinued operations

$                         

41,176
1,080,330

$                      

104,715
12,845

(999,597)
4,140,444
(499,173)
3,763,180

$                  

-
-
-
117,560

$                      

15. 

RELATED PARTY TRANSACTIONS AND BALANCES 

15.1  Related party transactions 

During the year ended December 31, 2019, the Company recorded related party transactions 
with management including: 

• 

The issuance of 800,000 common shares to executive management of the Company 
to settle employee remuneration, see Note 10.2. 

During the year ended December 31, 2018, the Company recorded related party transactions 
with directors, management and shareholders including: 

• 

• 

• 

• 

• 

Interest accruing to certain shareholders of the Company on the Shareholders’ Loan, 
see Note 7.1; 
The issuance of 11,269,243 common shares to settle the Shareholders’ Loan, see Note 
7.1; 
The issuance of 186,512 common shares to a shareholder of the Company to settle 
trade and other payables, see Note 10.2; 
The issuance of 578,822 common shares to a director of the Company to settle trade 
and other payables, see Note 10.2; and 
The issuance of 450,000 common shares to executive management of the Company 
to settle employee remuneration, see Note 10.2. 

Page | 43 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
                           
                       
                                   
                     
                                   
                       
                                   
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
15. 

RELATED PARTY TRANSACTIONS AND BALANCES (Continued) 

15.2  Key management personnel compensation 

The  remuneration  of  the Company’s  directors and  other  key management  personnel,  who 
have the authority and responsibility for planning, directing and controlling the activities of 
the Company, consisted of the following: 

Year ended December 31,
2019
2018

Salaries and benefits *
Consulting and professional fees
Share-based compensation

$                      

$                      

837,365
161,881
207,595
1,206,841

841,476
139,926
200,791
1,182,193

$                  

$                  

* Salaries and benefits are included in administrative expenses (Note 12) and exploration and 
evaluation assets (Note 6). 
15.3  Related party liabilities 

As at December 31,

2019

2018

Trade and other payables - current
Trade and other payables - non-current

$                      

$                      

276,042
70,000
346,042

176,422
150,000
326,422

$                      

$                      

Included  in  trade  and  other  payables  as  at  December  31, 2019  and 2018  is $346,042  and 
$326,422,  respectively,  owing  to  related  parties  of  the  Company,  of  which  $170,000  and 
$230,000, respectively, is owed to a former director of the Company.  On February 14, 2018, 
the Company entered into an amended severance agreement with this director to pay the 
remaining severance payments over 49 months, whereby the amount payable was increased 
to $370,000.  During the year ended December 31, 2019 and 2018, the Company paid the 
former director $60,000 and $140,000, respectively, towards the outstanding balance.  The 
Company has classified $100,000 as current and $70,000 as non-current as at December 31, 
2019 and $80,000 as current and $150,000 as non-current as at December 31, 2018.  In June 
2018, the Company settled other deferred compensation of $187,500 with this same former 
director through the issuance of 578,822 common shares of the Company, see Note 10.2.  

Page | 44 

 
 
 
 
 
 
 
 
 
  
 
 
 
                         
                         
                         
                         
                           
                         
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
16.  

FINANCIAL INSTRUMENTS AND RISK MANAGEMENT 

16.1  Categories of financial instruments 

Financial instruments are classified into one of the following categories: FVTPL; FVTOCI; or, 
at amortized cost. The carrying values of the Company’s financial instruments are classified 
into the following categories: 

As at December 31,

Financial assets

Amortized cost

Cash
Restricted cash
Reclamation bonds

Financial liabilities

Amortized cost

2019

2018

$                      

$                      

$                      

184,447
22,716
-
207,163
As at December 31,

$                      

352,001
39,963
99,000
490,964

2019

2018

Trade and other payables
Decommissioning liabilities
Operating lease obligations

Fair value through profit or loss

$                      

863,864
251,550
115,459

$                  

1,452,085
223,442
-

Warrant liabilities

$                  

265,029
1,495,902

$                  

247,654
1,923,181

Page | 45 

 
 
 
 
 
 
 
 
 
 
 
 
                           
                           
                                   
                           
                         
                         
                         
                                   
 
 
 
 
 
                         
                         
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
16.  

FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued) 

16.2  Fair value 

The  fair  value  of  financial  assets  and  financial  liabilities  measured  at  amortized  cost  is 
determined in accordance with generally accepted pricing models based on discounted cash 
flow analysis or using prices from observable current market transactions.  The Company 
considers that the carrying amount of all its financial assets and financial liabilities measured 
at amortized cost approximates their fair value. 

The Company’s financial instruments recorded at fair value require disclosure about how the 
fair  value  was  determined  based  on  significant  levels  of  inputs  described  in  the  following 
hierarchy: 
• 

• 

• 

Level  1  fair  value  measurements  are  those  derived  from  quoted  prices  in  active 
markets for identical assets or liabilities. 
Level  2  fair  value  measurements  are  those  derived  from  inputs  other  than quoted 
prices included within Level 1, that are observable either directly or indirectly.  
Level 3 fair value measurements are those derived from valuation techniques that 
include inputs that are not based on observable market data. 

The fair value of the Company’s warrant liabilities is recorded at fair value using Level 3 of 
the fair value hierarchy.  The carrying value of the warrant liabilities is determined using the 
Black-Scholes option pricing model. 

The  carrying  values  of  cash  and  trade  and  other  payables  approximate  their  fair  values 
because of the short-term nature of these financial instruments and are classified as financial 
assets and liabilities at amortized cost and are reported at amortized cost. 

The carrying values of restricted cash, reclamation bonds, decommissioning liabilities, and 
operating lease obligations approximate their fair values and are classified as financial assets 
and liabilities at amortized cost and are reported at amortized cost. 

Page | 46 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
16.  

FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued) 

16.3  Financial risk management objectives and policies

The  financial  risk  arising  from  the  Company’s  operations  are  market  risk,  credit  risk,  and 
liquidity risk.  These risks arise from the normal course of operations and all transactions 
undertaken are to support the Company’s ability to continue as a going concern.  The risks 
associated with these financial instruments and the policies on how to mitigate these risks 
are set out below.  Management of the Company manages and monitors these exposures to 
ensure appropriate measures are implemented on a timely and effective manner. During the 
year ended December 31, 2019, there were no significant changes in the Company’s financial 
risk management objectives and policies. The Company’s risk exposure and the impact on the 
Company’s financial instruments are summarized below:

Market risk 

Market risk is the risk that the fair value of the future cash flows of a financial instrument will 
fluctuate  due  to  changes  in  market  factors.  Market  risk  comprises  three  types  of  risks: 
currency risk, price risk and interest rate risk: 

Currency risk 

Currency risk is the risk that the fair values or future cash flows of the Company’s 
financial instruments will fluctuate because of changes in foreign currency exchange 
rates. The Company is exposed to currency risk through financial assets and liabilities 
denominated in currencies other than the United States Dollar.  Management believes 
the currency risk related to currency conversions is minimal and therefore, does not 
hedge its currency risk. 

Price risk 

Price risk is the risk that the fair value of future cash flows of the Company’s financial 
instruments  will  fluctuate  because  of  changes  in  market  prices.  The  Company  is 
exposed  to  the  risk  of  fluctuations  in  prevailing  market  prices  for  its  uranium 
products.    However,  as  the  Company  is  currently  an  exploration  and  development 
stage company, the risk is insignificant. 

Interest rate risk 

Interest rate risk is the risk that the fair values and future cash flows of the Company 
will fluctuate because of changes in market interest rates. The Company is exposed to 
interest rate risk to the extent that the cash maintained at the financial institutions is 
subject to a floating rate of interest. The interest rate risk on cash is not significant. 

Page | 47 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
16.  

FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued) 

16.3  Financial risk management objectives and policies (Continued)

Credit risk 

Credit  risk  is  the  risk  of  potential  loss  to  the  Company  if  the  counterparty  to  a  financial 
instrument fails to meet its contractual obligations. 

The Company is exposed to credit risk associated with its cash. The Company’s maximum 
exposure to credit risk is equal to the carrying amount of its cash. 

The  Company’s  credit  risk  on  cash  arises  from  default  of  the  counterparty.  The  Company 
limits  its  exposure  to  counterparty  credit  risk  on  cash  by  only  dealing  with  financial 
institutions with high credit ratings.  

Liquidity risk 

Liquidity risk is the risk that the Company will not be able to settle or manage its obligations 
associated  with  financial  liabilities.    The  Company’s  approach  to  managing  liquidity  is  to 
evaluate  current  and  expected  liquidity  requirements  under  both  normal  and  stressed 
conditions to ensure that it maintains sufficient reserves of cash, access to financing facilities 
or access to cash generating opportunities, such as the liquidation of non-core and redundant 
assets to meet expected expenditures.  The Company prepares annual expenditure budgets 
that are updated as necessary depending on various factors, including capital deployment, 
progress on permitting, results from the exploration and development of its properties and 
general industry conditions. The annual and updated budgets are approved by the Board of 
Directors. 

The  Company’s  current  and  expected  remaining  contractual  maturities  for  its  financial 
liabilities  with  agreed  repayment  periods  are  presented  below.    The  table  includes  the 
undiscounted  cash  flows  of  financial  liabilities  based  on  the  earliest  date  on  which  the 
Company can be required to satisfy the liabilities.  

As at December 31, 2019

1-3 months

3 months - 
1 year

Trade and other payables
Operating lease obligations

$        

$        

728,864
15,573
744,437

$        

65,000
40,610
105,610

$     

1-5 years

Total

$       

70,000
124,526
194,526

$    

$      

863,864
180,709
1,044,573

$   

Page | 48 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
          
       
         
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
17.   CAPITAL RISK MANAGEMENT 

The Company’s capital risk management objectives are to safeguard the Company’s ability to 
continue as a going concern to support the Company’s exploration and development of its 
mineral properties and to maintain a flexible capital structure which optimizes the costs of 
capital at an acceptable risk. 

The  Company  depends  on  external  financing  to  fund  its  activities  and  there  can  be  no 
guarantee that external financing will be available at terms acceptable to the Company. The 
Company  manages  its  capital  structure  and  adjusts  it  in  light  of  changes  in  economic 
conditions and the risk characteristics of the underlying assets.  To maintain or adjust the 
capital structure, the Company may issue new shares, issue new debt or acquire or dispose 
of assets. To facilitate management of its capital requirements, the Company prepares annual 
expenditure budgets that are updated as necessary depending on various factors, including 
capital deployment, progress on permitting, results from the exploration and development of 
its  properties  and  general  industry  conditions.    The  annual  and  updated  budgets  are 
approved by the Board of Directors. During the year ended December 31, 2019, there were 
no significant changes in the processes used by the Company or in the Company’s objectives 
and policies for managing its capital.  The Company is not subject to any externally imposed 
capital requirements. 

As at December 31, 2019, the Company’s capital structure consists of its equity, see Note 10. 

18.   COMMITMENTS 

Within 1 year

2-4 years

Over 4 years

Total

Annual license payments *
Centennial option 
agreement **
Dewey Burdock option 
agreements

$           

540,356

$           

390,097

$       

1,338,783

$       

2,269,236

-

-

3,165,000

3,165,000

62,500
602,856

$           

255,000
645,097

$           

1,638,750
6,142,533

$       

1,956,250
7,390,486

$       

* annual license payments include lease, mineral claim, and exploration license payments 
**  the  contingent  payments  are  payable  upon  receipt  of  regulatory  permits  and  licenses 
allowing  uranium  production  on  the  area  of  the  Centennial  Project  pertaining  to  these 
uranium interests.    Further,  since  the  required  licenses  and  permits  were not  received  by 
September 27, 2019, the uranium rights, at the option of the seller, can be transferred back 
to  the  seller.    The  Company  is  attempting  to  renegotiate  the  Centennial  Project  option 
agreement, see Note 6. 

Certain of the Company’s commitments may provide the Company with the ability to avoid 
funding those commitments; however, the Company discloses the contractual maturities of 
the Company's commitments based on management's intent. 

Page | 49 

 
 
 
 
 
 
 
 
 
 
 
 
                        
                        
          
          
                
              
          
          
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
19.  

SUPPLEMENTAL CASH FLOW INFORMATION 

During the year ended December 31, 2019, the Company completed the following non-cash 
investing and financing activities: 

• 

• 

• 

• 

• 

Issued  1,380,521  common  shares  to  settle  $231,424  owing  pursuant  to  the 
Company’s ESPP; 
Issued 323,553 common shares to settle $55,001 owing pursuant to the Company’s 
DSA; 
Issued  900,000  common  shares  to  settle  $170,068  of  outstanding  employee 
remuneration; 
Issued 6,553,022 share purchase warrants valued at $378,506 as part of the March 
2019 financing; and 
No cash interest or income taxes were paid. 

During the year ended December 31, 2018, the Company completed the following non-cash 
investing and financing activities: 

• 

• 
• 
• 

• 

• 
• 
• 

• 

• 

Issued  57,920,716  common  shares  valued  at  $11,237,756  for  acquisition  of  URZ 
Energy; 
Issued 186,393 common shares valued at $36,164 for transaction costs; 
Issued 11,269,243 common shares to settle the Shareholders’ Loan of $2,201,024; 
Issued  1,115,301  common  shares  to  settle  $215,344  owing  pursuant  to  the 
Company’s ESPP; 
Issued 303,937 common shares to settle $58,669 owing pursuant to the Company’s 
DSA; 
Issued 104,166 common shares to repurchase royalties for $19,391; 
Issued 2,033,334 common shares to settle trade and other payables of $391,014; 
Issued  550,000  common  shares  to  settle  $93,500  of  outstanding  employee 
remuneration; 
Issued  390,000  share  purchase  warrants  valued  at  $16,562  as  part  of  the  January 
2018 financing; and 
No cash interest or income taxes were paid. 

Page | 50 

 
 
 
 
 
 
 
 
  
 
 
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
20. 

NON-CONTROLLING INTEREST  

As at December 31, 2018, the Company held a 70.0% interest in UrAsia.  On May 23, 2019, the 
Company  acquired  an  additional  23.1%  interest  from  two  minority  shareholders  for  a 
nominal cost giving the Company a 93.1% interest in UrAsia.  In October 2019, the Company 
sold its 93.1% interest in UrAsia, see Note 6. 

Changes in the Company’s non-controlling interest for the years ended December 31, 2019 
and 2018 were as follows: 

Year ended December 31,
2019
2018

Balance, beginning of year
Non-controlling interest adjustment on 
acquisition of 23.1% of UrAsia
Non-controlling interest share of net loss
Non-controlling interest from other 
comprehensive income (loss)
Balance, end of year

$                    

(494,477)

$                    

(449,996)

753,411
(273,923)

-
(29,435)

14,989
$                                
-

$                    

(15,046)
(494,477)

Set  out  below  is  the  summarized  financial  information  for  100%  of  UrAsia’s  net  assets 
(liabilities), total comprehensive income (loss) and cash flows. The information is presented 
before considering inter-company consolidation and elimination adjustments. 

As at
September 30,
2019

As at
December 31,
2018

Current

Assets
Liabilities
Total current net liabilities
Non-current

Assets
Liabilities
Total non-current net assets

$                               

841
(338,169)
(337,328)

$                      

129,395
(424,147)
(294,752)

30,405
-
30,405

4,187,711
(975,342)
3,212,369

Net assets (liabilities)

$                    

(306,923)

$                  

2,917,617

* September 30, 2019 financial information is presented above, being the assets and liabilities 
sold 

Page | 51 

 
 
 
 
 
 
 
 
 
 
 
 
 
                         
                                   
                       
                         
                           
                         
                       
                       
                       
                       
                           
                     
                                   
                       
                           
                     
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
20. 

NON-CONTROLLING INTEREST (Continued) 

Period ended
September 30,
2019

Year ended
December 31,
2018

Net loss before tax
Deferred income tax recovery (expense)
Net loss
Other comprehensive income (loss)
Total other comprehensive loss

$                

$                    

(3,763,180)
(16,238)
(3,779,418)
863,092
(2,916,326)

(117,560)
17,222
(100,338)
(35,108)
(135,446)

$                

$                    

* Nine months ended September 30, 2019 financial information is presented above, being the 
loss for the period prior to the sale of UrAsia 

Period ended
September 30,
2019

Year ended
December 31,
2018

$                    

$                    

Net cash used in operating activities
Net cash generated from investing activities
Net cash generated from financing activities
Change in cash
Cash, beginning of period
Effect of foreign exchange rate changes on cash
Cash, end of period

(228,218)
99,700
-
(128,518)
129,395
(36)
841

$                               

$                      

(160,580)
260,172
-
99,592
30,556
(753)
129,395

* Nine months ended September 30, 2019 financial information is presented above, being the 
cash flows for the period prior to the sale of UrAsia 

Page | 52 

 
 
 
 
 
 
 
 
 
 
 
 
 
                         
                           
                   
                       
                         
                         
                           
                         
                                        
                                        
                       
                           
                         
                           
                                  
                                
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
21.  DEFERRED INCOME TAX 

21.1  Deferred income tax  

Taxation on profits or losses has been calculated on the estimated assessable profits or losses 
for  the  year  at  the  rates  of  taxation  prevailing  in  the  jurisdictions  in  which  the  Company 
operates. 

21.2  Deferred income tax expenses 

Year ended December 31,
2019
2018

Net loss before income tax
Statutory tax rate
Deferred income tax recovery based on 
statutory rate
Effect of different tax rates applicable in 
foreign jurisdictions
Effect of disposition of subsidiary
Unrecognized deferred tax assets
Effect of non-deductible expenses and non-
taxable revenue and other
Deferred income tax (expense) recovery

21.3  Deferred tax balances 

$                  

4,096,816
27%

$                  

2,110,165
27%

$                  

1,106,000

$                      

570,000

(163,000)
(346,000)
(270,000)

(46,000)
-
(966,000)

$                      

(205,000)
122,000

$                    

261,000
(181,000)

The Company’s deferred tax liabilities consist of the following amounts:  

As at December 31,

2019

2018

Exploration and evaluation assets
Inter-company loans eliminated on 
consolidation
Deferred tax liabilities

$                  

3,112,193

$                  

3,119,790

-

$                  

3,112,193

$                  

1,114,000
4,233,790

As at December 31, 2019 and 2018, the Company has not recognized any deferred tax assets. 

Page | 53 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       
                         
                       
                                   
                       
                       
                       
                         
                                   
                     
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
21.   DEFERRED INCOME TAX (Continued) 

21.3  Deferred tax balances (Continued) 

Changes in the Company’s deferred tax liabilities for the years ended December 31, 2019 and 
2018 were as follows: 

Year ended December 31,
2019
2018

Opening balance 
Reversal of deferred income tax on inter-
company loans
Deferred income tax (recovery) expense 
Deferred tax liabilities 

$                  

4,233,790

$                  

4,052,790

(999,597)
(122,000)
3,112,193

$                  

-
181,000
4,233,790

$                  

21.4  Unrecognized deductible temporary differences and unused tax losses  

The  Company’s  deductible  temporary  differences  and  unused  tax  losses  for  which  no 
deferred tax asset is recognized consist of the following tax affected amounts: 

As at December 31,

2019

2018

Non-capital losses
Deductible temporary differences
Total unrecognized amounts

$                  

$                  

3,812,000
44,000
3,856,000

3,565,000
21,000
3,586,000

$                  

$                  

As  at  December  31,  2019  and  2018,  the  Company  had  unrecognized  deferred  tax  assets 
attributable to deductible temporary differences of $44,000 and $21,000, respectively, which 
are primarily related to value added tax receivables and certain deferred payments not being 
recognized. 

The deferred tax assets related to the temporary differences and non-capital losses were not 
recognized as their recoverability was not considered to be probable. 

Corporate  taxpayers  in  the  USA  that  generate  a  loss  in  a  taxable  year  beginning  after 
December 31, 2017, will be able to carry forward the NOL indefinitely but utilization will be 
subject to an annual deduction limitation of 80 percent of taxable income. The losses will not 
be allowed to be carried back. 

Page | 54 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       
                                   
                       
                         
                           
                           
AZARGA URANIUM CORP. 
Notes to the Consolidated Financial Statements 

(Expressed in U.S. Dollars and in shares, unless otherwise indicated) 
For the year ended December 31, 2019 
21.   DEFERRED INCOME TAX (Continued) 

21.5  Expiry dates 

The expiry dates of the Company’s unused tax losses are as follows: 
Non-capital losses

As at December 31, 2019

United States
Canada
Hong Kong

22. 

SUBSEQUENT EVENTS  

$                  

$                

7,688,000
8,092,000
651,000
16,431,000

2027 to indefinite
2027 to indefinite
Indefinite

Subsequent to December 31, 2019, the Company completed the following transactions: 
• 

In January 2020, the Company issued 457,618 common shares to settle $71,877 owing 
pursuant  to  the  Company’s  ESPP  and  87,543  common  shares  to  settle  $13,750  owing 
pursuant to the Company’s DSA; and 

• 

In February 2020, the Company received third party loans of C$325,000 that bear interest 
at 12% per annum, are unsecured, and mature August 4, 2020. 

Page | 55 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
                         
Azarga Uranium Corp. 
MANAGEMENT’S DISCUSSION AND ANALYSIS 

For the year ended December 31, 2019 
(Expressed in U.S. Dollars) 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

The  following  is  management’s  discussion  and  analysis  (“MD&A”)  of  the  results  of 
operations and financial condition of Azarga Uranium Corp. (“Azarga Uranium”) for the 
year ended December 31, 2019 and up to the date of this MD&A, and should be read in 
conjunction  with  the  accompanying  audited  consolidated  financial  statements  for  the 
year ended December 31, 2019, together with the notes thereto (the “Financial Report”). 

All  financial  information  in  this  MD&A  is  derived  from  the  Company’s  consolidated 
financial  statements  prepared  in  accordance  with  International  Financial  Reporting 
Standards (“IFRS”). All references to $ in this MD&A refer to the United States dollar and 
all references to C$ refer to the Canadian dollar. 

Additional information relating to the Company, including the Annual Information Form, 
is available under the Company’s profile on SEDAR at www.sedar.com 

The effective date of this MD&A is March 26, 2020. 
DESCRIPTION OF THE BUSINESS

Azarga Uranium was incorporated on February 10, 1984 under the laws of the Province 
of British Columbia, Canada. Azarga Uranium’s common shares are publicly traded on the 
Toronto Stock Exchange (“TSX”) (Symbol: AZZ), the Frankfurt Stock Exchange (Symbol: 
P8AA), and the OTCQB Venture Market (Symbol: AZZUF). The Company is an integrated 
uranium exploration and development company.  

The Company controls uranium properties in the United States of America (the “USA”), 
located in South Dakota, Wyoming, Utah and Colorado, with a primary focus of developing 
in-situ recovery  (“ISR”)  uranium  projects. The Dewey  Burdock ISR uranium project in 
South Dakota, USA (the “Dewey Burdock Project”) is the Company’s initial development 
priority and has received its Nuclear Regulatory Commission (“NRC”) license and draft 
Class  III  and  Class  V  Underground  Injection  Control  (“UIC”)  permits  from  the 
Environmental  Protection  Agency  (the  “EPA”).    The  Company  also  owns  the  Gas  Hills, 
Juniper Ridge, Dewey Terrace and Aladdin Projects in Wyoming, the Centennial Project 
in Colorado, and uranium exploration properties in Wyoming, Utah and Colorado. 

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

OPERATIONAL HIGHLIGHTS 

The Company’s significant events and highlights for the year ended December 31, 2019 
and to the date of this MD&A are as follows: 

•  Dewey Burdock Project

• 

• 

• 

In January 2020, the Company filed a National Instrument 43-101 (“NI 43-
101”) Technical Report and Preliminary Economic Assessment (“PEA”) for 
the Dewey Burdock Project. The base case economic assessment resulted 
in a pre-income tax internal rate of return (“IRR”) of 55% and a pre-income 
tax net present value (“NPV”) of US$171.3 million when applying an eight 
percent discount rate.  Using the same discount rate, the post-income tax 
IRR is 50% and the post-income tax NPV is US$147.5 million. 

In  December  2019,  the  Atomic  Safety  and  Licensing  Board  (the  “ASLB”) 
issued its Final Initial Decision and resolved the final remaining contention 
on  the  Company’s  Dewey  Burdock  Project  NRC  License  in  favor  of  the 
Company and NRC Staff. 

In August 2019, the Company received notice that the EPA issued revised 
draft  permits for the  Dewey  Burdock Project.  The revised draft  permits 
incorporate comments submitted to the EPA on the original draft permits, 
including  comments  submitted  by  the  Company  and  pertain  to  the 
Company’s planned Class III and Class V UIC activities. The revised draft 
EPA  permits  addressed  the  majority  of  the  comments  submitted  by  the 
Company. This is a significant step towards the issuance of the final EPA 
permits  and  continues  to  advance  the  Dewey  Burdock  Project  towards 
development. The Company remains focused on working with the EPA to 
obtain the final permits in the near-term. 

•  Private Placement

 – In March 2019, the Company closed a non-brokered private 
placement for gross proceeds of $2,266,169 (C$3,014,391) through the issuance 
of 13,106,046 units at a price of C$0.23 per unit.  Each unit consists of one common 
share and one-half of one share purchase warrant.  Each whole warrant entitles 
the holder thereof to purchase one common share at a price of C$0.31 per share 
until March 20, 2022. 

•  Kyzyl Ompul Project – Kyrgyz Republic 

– In October 2019, the Company sold its 
93.1% interest in the Kyzyl Ompul Project located in the Kyrgyz Republic for cash 
consideration of $232,750.  In addition, the Company was granted a 1.862% net 
smelter return (“NSR”) royalty on any future uranium production from the Kyzyl 
Ompul Project up to $4,665,000.

3 

 
 
 
 
 
 
  
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

INDUSTRY TRENDS AND OUTLOOK 

Although uranium prices have recovered from their lows in the fourth quarter of 2016, 
the  Company  believes  that  the  following  key  elements  will  contribute  to  further 
improvements in the uranium sector: 

•  Global reactor pipeline indicates growth

1 

 – the global reactor pipeline consists 
nuclear  reactors  that  are  operable,  under  construction,  planned  or 
1
1
.  A total of 163

of  935
proposed.  Of the 935 nuclear reactors, 442 reactors are operable
nuclear  reactors  are  under  construction  or  planned,  which  represents 
approximately 37% of the current operating fleet. China, and India lead the world 
in terms of the number of nuclear power plants under construction, with eleven 
1
and seven, respectively
. China continues to accelerate their nuclear growth plans 
2
and  intends  to  have  120-150  GWe  of  installed  capacity  by  2030
  (currently  46 
GWe

1
). 

•  Current prices are constraining supply

 – low prices are forcing producers to 
curtail mining, development and exploration. In 2016, Cameco Corp. (“Cameco”) 
placed  its  Rabbit  Lake Mine,  which  produced  4.2  million  pounds  of  uranium  in 
3
,  on  care  and  maintenance,  and  curtailed  its  United  States  uranium 
2015
operations.  In 2017, Cameco announced temporary production suspensions at its 
McArthur River/Key Lake operation, which Cameco expected would remove 18 
4
.    In  July  2018,  Cameco 
million  pounds  of  uranium  from  the  market  in  2018
announced the decision  to  continue  the shutdown of McArthur River/Key  Lake 
indefinitely.  Further,  Kazatomprom  announced  a  20%  production  cut  over  a 
5
  and  subsequent  to  this 
period  of  three  years  commencing  in  January  2018
announcement that the 20% production cut would be extended until at least 2021. 
This 20% production cut by Kazatomprom is expected to remove approximately 
3
from global primary supply in 2021.  Global primary 
O
14.6 million pounds of U
supply is well below nuclear reactor requirements. 

8 

•  United  States  Nuclear  Fuel  Working  Group

  –  In  July  2019,  President  Trump 
established  the  United  States  Nuclear  Fuel  Working  Group  (the  “NFWG”)  to 
develop  recommendations  for  reviving  and  expanding  domestic  nuclear  fuel 
production.   President  Trump  acknowledged  that  the  “United  States  uranium 
industry faces significant challenges in producing uranium domestically and that 
this is an issue of national security.”  Subsequently, in February 2020, President 
Trump’s  fiscal 2021  budget  proposal requested an annual allocation of US$150 
million for a 10-year period, totalling US$1.5 billion, to establish a United States 
uranium reserve, noting that “establishing a uranium reserve provides assurance 

1 World Nuclear Association – World Nuclear Power Reactors & Uranium Requirements (January 2020) 
2 World Nuclear Association – Nuclear Power in China (January 2020) 
3 Cameco 2016 Annual Information Form dated March 23, 2017 
4 Cameco Corp. Management Discussion & Analysis for the quarter ended June 30, 2018 
5 NAC “Kazatomprom” JSC news release dated December 4, 2017 

4 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

of  availability  of  uranium  in  the  event  of  a  market  disruption  and  supports 
strategic U.S. fuel cycle capabilities.” The proposed fiscal 2021 budget “addresses 
immediate  challenges  to  the  production  of  domestic  uranium  and  reflects  the 
Administration's  NFWG  priorities.  The  NFWG  will  continue  to  evaluate  issues 
related to uranium supply chain and fuel cycle.” 

Despite  the  Company’s  belief  that  a  uranium  sector  turnaround  has  commenced,  its 
strategies are focused on making prudent plans to progress its business, while conserving 
its financial resources. At this time, the Company’s strategy involves the following key 
elements: 

•  Continue with the advancement of the Dewey Burdock Project

 – the Company 
remains focused on working with the EPA to obtain the final Class III and Class V 
UIC  permits  in  the  near-term.    In  August  2019,  the  EPA  issued  revised  draft 
permits that addressed the majority of the comments submitted by the Company. 
In parallel with advancing the Dewey Burdock Project on the permitting front, the 
Company  will  continue  to  evaluate  project-financing  options,  with  a  view  to 
having a funding solution in place prior to or concurrent with the finalization of 
permits. 

•  Focus on identifying uranium resources at the Dewey Terrace Project

 – the 
Company is continuing the evaluation and analysis of historical data at the Dewey 
Terrace Project with the goal of identifying additional uranium mineralization. 
•  Focus on identifying additional uranium resources and ISR amenability at 
the Gas Hills Project

 – the Company is in the process of reviewing historical data 
at  the  Gas  Hills  Project  with  the  goal  of  identifying  additional  uranium 
mineralization.    The  Company  has  also  completed  hydrological  studies,  which 
indicate that permeability and piezometric surface conditions are suitable for ISR 
uranium mining. The Company will continue to evaluate future ISR development 
options  at  Gas  Hills,  consistent  with  the  Company’s  strategy  of  developing  ISR 
uranium projects in the USA. 

•  Future uranium production off-take 

– the Company will continue engaging with 
potential  customers  for  future  uranium  production  off-take.  Although  the 
Company plans to continue these discussions, in parallel with the advancement of 
the Dewey Burdock Project, the level of these activities will be dependent on the 
market environment.  

The Company expects to successfully execute its strategy as the Company believes that: 

• 

• 

uranium prices will move higher in the near to medium term; 

the December 2019 PEA demonstrates that the Dewey Burdock Project is one of 
the United States’ preeminent undeveloped ISR uranium projects; 

5 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

• 

• 

• 

on completion of permitting at the Dewey Burdock Project, the Company expects 
to be able to attract financing and move into the construction phase;  

the  Company’s  asset  suite  includes  mineral  properties  at  various  stages  of 
development, providing a pipeline for continued growth; and  

management and the Board of Directors  have extensive experience in uranium, 
the broader mining sector and financial markets.

MINERAL PROPERTIES 

The Dewey Burdock Project (100% interest) – South Dakota, USA 

The Company’s 100% owned Dewey Burdock Project is an ISR uranium project located 
in  the  Edgemont  uranium  district,  in  South  Dakota,  USA.  Through  property  purchase 
agreements,  mining  leases  and/or  mining  claims,  the  Dewey  Burdock  Project  is 
comprised  of  approximately  12,613  surface  acres  and  16,962  net  mineral  acres.    The 
Dewey Burdock Project is the Company’s initial development priority.   
Summary of Mineral Resources and PEA 

In January 2020, the Company filed a NI 43-101 compliant independent Technical Report 
and PEA for the Dewey Burdock Project prepared by Woodard & Curran and Rough Stock 
Mining Services (the “Dewey Burdock PEA”) with an effective date of December 3, 2019. 

Dewey Burdock Project ISR Mineral Resource Estimate 

Measured 
Resources 
5,419,779 
0.132 
5.56 
0.733 

Indicated 
Resources 
1,968,443 
0.072 
5.74 
0.413 

Measured 
plus 
Indicated 
Resources 
7,388,222 
0.116 
5.65 
0.655 

Inferred 
Resources 
645,546 
0.055 
5.87 
0.324 

14,285,988 

2,836,159 

17,122,147 

712,624 

Tons 
8
3
) 
Average grade (%U
O
Average thickness (feet) 
Average  grade-thickness 
(“GT”) 
Uranium  (pounds)  at  a 
0.20 GT cut-off 

Note:  mineral  resources  that  are  not  mineral  reserves  do  not  have  demonstrated 
economic viability. 

In  addition  to  the  ISR  mineral  resource  estimate,  the  NI  43-101  resource  estimate 
includes a non-ISR (located above the water table) mineral resource estimate containing 
8
3
measured resources of 857,186 pounds at 0.060% U
, indicated resources of 407,851 
O
3
8
3
pounds at 0.053% U
at a 
O
 and inferred resources of 114,858 pounds at 0.051% U
O
0.20  GT  cut-off.  The  non-ISR  mineral  resource  estimate  is  not  included  in  the  mineral 

8 

6 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

resource figures presented in the economic analysis for the Dewey Burdock PEA.  Mineral 
resources that are not mineral reserves do not have demonstrated economic viability. 

The Dewey Burdock PEA resulted in a pre-income tax NPV of $171.3 million at a discount 
rate of 8% and an IRR of 55% compared to a post-income tax NPV of $147.5 million at a 
discount  rate  of  8%  and  an  IRR  of  50%.    The  Dewey  Burdock  PEA  post-  income  tax 
calculations do not include a corporate level assessment of income tax liabilities; taxes 
have only been calculated at the Dewey Burdock Project level. The estimate of income tax 
at the corporate level is subject to a number of additional considerations that have not 
been  factored  in  when  calculating  income  taxes  at  the  project  level, including,  but  not 
limited to, the capital structure to finance the Dewey Burdock Project, which has not yet 
been determined and loss carry forwards available at the corporate level.  

8
3
The Dewey Burdock PEA estimated uranium prices of $55/lb U
, direct cash operating 
O
costs of $10.46 per pound of production and royalties and local taxes (excluding property 
tax)  of  $5.15  per  pound  of  production.    The  total  pre-income  tax  cost  of  uranium 
production  is  estimated  to  be  $28.88  per  pound  of  production.    Income  taxes  are 
estimated to be $3.39 per pound of production.   

Initial capital expenditures are estimated at $31.7 million.  The Dewey Burdock Project is 
3
8
 over its 16 years of production and the 
O
forecast to produce 14.3 million pounds of U
projected  cash  flows  of  the  Dewey  Burdock  Project  are  expected  to  be  positive  in  the 
second year of production, two years after the commencement of construction.     

Details of the assumptions and parameters used with respect to the Dewey Burdock PEA, 
including information on data verification, are set out in the “NI 43-101 Technical Report 
Preliminary Economic Assessment, Dewey Burdock Uranium ISR Project, South Dakota, 
USA, dated January 17, 2020, with an effective date of December 3, 2019, a copy of which 
is available under the Company’s profile at www.sedar.com. The Dewey Burdock PEA is 
preliminary  in  nature;  it  includes  inferred  mineral  resources  that  are  considered  too 
speculative geologically to have the economic considerations applied to them that would 
enable them to be categorized as mineral reserves. There is no certainty that the Dewey 
Burdock PEA will be realized. Mineral resources that are not mineral reserves do not have 
demonstrated economic viability.  

7 

 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Summary of Permitting  

Permit, License or Approval Name 

Agency 

UIC Class III Permit 

EPA 

UIC Class V Permit 

Final Source and By-product 
Materials License 

NRC 

Ground Water Disposal Plan  

DENR 

Water Rights Permit 

Large Scale Mine Plan Permit 

Plan of Operations  

BLM 

• 

• 

• 

• 

• 

• 

Status 

Revised draft permits issued 
August 2019  
Working with EPA to obtain 
final permits in near-term 

Issued April 2014 and in 
good standing 

Applications complete and 
recommended for 
conditional approval by 
DENR staff  
Hearings for final approval 
commenced in late-2013, 
continuance ordered until 
completion of federal 
regulatory approvals (NRC 
and EPA) 

Approval anticipated to 
follow resolution of final 
NRC license contention 

 DENR
EPA
NRC  
BLM  

South Dakota Department of Environment and Natural Resources 
United States Environmental Protection Agency 
United States Nuclear Regulatory Commission 
Bureau of Land Management 

The NRC issued the final Supplemental Environment Impact Statement (“SEIS”) for the 
Dewey  Burdock  Project  in  the  first  quarter  of  2014.  The  Section  106  programmatic 
agreement  (“PA”)  was  executed  on  April  7,  2014  by  the  Advisory  Council  on  Historic 
Preservation, the NRC, the South Dakota State Historic Preservation Office and the BLM. 
Subsequent to the PA being executed, the NRC issued a final Safety Evaluation Report and 
the  Company’s  Dewey  Burdock  Project  received  its  Source  and  Byproduct  Materials 
License SUA-1600 on April 8, 2014, covering 10,580 acres.  In the fourth quarter of 2016, 
the Company received approval from the NRC for the first amendment to the NRC license, 
which completed certain NRC license conditions. The Company controls the mineral and 
surface rights for the area pertaining to the NRC license. 

In  August  2014,  an  evidentiary  hearing  was  held  with  the  ASLB  in  regard  to  the 
contentions raised with respect to the Dewey Burdock Project. These ASLB hearings are 
normal practice and are undertaken after the NRC license has been granted to determine 

8 

 
 
 
 
 
 
 
 
  
  
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

whether the NRC staff has considered all issues related to the NRC license. In April 2015, 
the  ASLB  ruled  on  seven  contentions  raised  by  the  consolidated  intervenors  and  the 
Oglala  Sioux  Tribe  (collectively,  the  “Intervenors”)  regarding  the  NRC  license  for  the 
Dewey  Burdock  Project.  For  five  contentions,  including  those  related  to  groundwater 
usage, groundwater quality, ability to contain fluid migration, mitigation measures, and 
connected  actions,  the  ASLB  ruled  in  favor  of  the  NRC  staff  and  the Company.  For  the 
remaining two contentions, which related to identification and protection of historic and 
cultural resources, the ASLB requested additional consultation between the NRC staff and 
the Oglala Sioux Tribe.  The ASLB also ruled inadmissible two new contentions that were 
filed by the Intervenors after the evidentiary hearing.  

Subsequent to the ASLB partial initial decision in April 2015, the Company and the NRC 
staff filed petitions for review of the ASLB decision to the NRC Commission with respect 
to  their  ruling  that  additional  consultation  efforts  were  required  between  the  Oglala 
Sioux Tribe and the NRC staff regarding the two contentions relating to the identification 
and  protection  of  historic  and  cultural  resources.  The  Intervenors  filed  petitions  for 
review of the ASLB  decision to  the  NRC Commission covering most of the  contentions 
heard  by  the  ASLB.  Upon  consideration  of  the  information  presented,  the  NRC 
Commission  denied  the  party’s  petitions  for  review  of  the  ASLB  decision,  with  the 
exception of 1) the NRC staff’s and the Company’s petition for review with respect to the 
ASLB’s  direction  to  the  NRC  staff  regarding  the  resolution  of  the  outstanding  two 
contentions  relating  to  the  identification  and  protection  of  historic  and  cultural 
resources, in which the NRC Commission ultimately affirmed the ASLB’s decision and 2) 
a petition for review filed by the Oglala Sioux Tribe claiming that the draft SEIS had been 
issued without the requisite scoping process, in which the NRC Commission affirmed the 
ASLB’s decision and dismissed the contention. 

In  August  2017,  the  Company  received  notice  that  the  NRC  staff  filed  a  motion  for 
summary disposition before the ASLB to resolve the remaining two contentions from the 
ASLB partial initial decision.  The Company filed a brief in support of the NRC staff motion, 
while the Intervenors filed briefs opposing the motion.  In October 2017, the ASLB issued 
a memorandum and  order  pertaining to this motion.   With respect to  the  outstanding 
contention requiring additional consultation between the NRC staff and the Oglala Sioux 
Tribe  under  the  National  Historic  Preservation  Act,  the  ASLB  granted  the  motion  for 
summary  disposition  in  favor  of  the  NRC  staff  and  the  Company.  With  respect  to  the 
outstanding  contention  pertaining  to  the  identification  and  protection  of  historic  and 
cultural resources for the purposes of compliance with the National Environmental Policy 
Act (“NEPA”), the ASLB did not grant the motion for summary disposition.  As a result, 
the  Company  filed  an  appeal  with  the  NRC  Commission  in  an  effort  to  resolve  the 
remaining contention; however, the appeal was not successful.  

In 2018, the Company, the NRC staff and the Oglala Sioux Tribe agreed, in principle, to a 
process for resolving the remaining contention; however, due to differences in approach 
between the Oglala Sioux Tribe and the NRC staff, both parties filed motions for summary 
disposition.    The  Company  filed  a  brief  in  support  of  the  NRC  staff  motion.  The  ASLB 
denied the Oglala Sioux Tribe’s motion for summary disposition and its request to stay or 

9 

 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

revoke the Company’s Dewey Burdock Project NRC license and the NRC staff’s summary 
disposition motion to resolve the remaining contention.  In May 2019, the ASLB issued 
an  order  granting  the  NRC  staff’s  motion  to  set  a  schedule  for  an  evidentiary  hearing 
pertaining  to  the  final  contention.    The  ASLB  decision  provides  the  NRC  staff  and  the 
Company  with  an  opportunity  to  resolve  the  final  contention  for  the  Dewey  Burdock 
Project NRC license within legally established timelines.  The NRC staff determined that 
an  evidentiary  hearing,  one  of  the  two  options  previously  presented  by  the  ASLB  to 
address the only remaining contention, was the most appropriate path forward as the 
other  approach  did  not  have  a  reasonable  expectation  of  agreement  in  an  acceptable 
timeframe.  In December 2019, the ASLB issued its Final Initial Decision and resolved the 
final  remaining  contention  for  the  Dewey  Burdock  Project  NRC  license  in  favor  of  the 
Company and NRC staff.  Subsequently, the Intervenors have appealed this decision to 
the NRC Commission. 

In February 2017, the Oglala Sioux Tribe filed an appeal of the decision made by the NRC 
Commission to the United States Court of Appeals for the District of Columbia Circuit (the 
“DC Circuit Court”).  On July 23, 2018, the Company reported that the DC Circuit Court 
issued an order dismissing most of the rulings challenged by the Oglala Sioux Tribe due 
to lack of jurisdiction; however, the DC Circuit Court remanded the decision to keep the 
Company’s  NRC  license  in  effect  to  the  NRC  Commission  due  to  the  unresolved  NEPA 
contention. On January 31, 2019, the NRC Commission issued a decision upholding the 
effectiveness of the Company’s NRC license in consideration of the remand from the DC 
Circuit Court.  

The NRC license for the Dewey Burdock Project continues to remain in good standing. 

The  Company  continues  to  be  in  compliance  with  the  existing  conditions  of  the  NRC 
license  and  other  permitting  and  licensing  requirements.  Prior  to  commencing 
construction  and  operations  at  the  Dewey  Burdock  Project,  the  Company  requires 
regulatory  approvals  from  two  other  major  agencies,  the  EPA  and  the  DENR.  These 
approvals include the final Class III and Class V UIC permits from the EPA and three state 
permits to be issued by the DENR. 

Additional requirements  that  need  to be  addressed prior to  commencing  construction 
and operations at the Dewey Burdock Project include the satisfaction of pre-operational 
conditions under the NRC license and the development and implementation of mitigation 
plans for protection of cultural resources under the PA. 

In August 2019, the Company received notice that the EPA issued revised draft permits 
for  the  Dewey  Burdock  Project.    The  revised  draft  permits  incorporate  comments 
submitted to the EPA on the original draft permits, including comments submitted by the 
Company and pertain to the Company’s planned Class III and Class V UIC activities. The 
revised  draft  EPA  permits  addressed  the  majority  of  the  comments  submitted  by  the 
Company.  This  is  a  significant  step  towards  the  issuance  of  the  final  EPA  permits  and 
continues to advance the Dewey Burdock Project towards development. The Company 
remains focused on working with the EPA to obtain the final permits in the near-term. 

10 

 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

The Company submitted applications to the DENR in 2012 for its Groundwater Discharge 
Plan (“GDP”), Water Rights (“WR”) and Large Scale Mine Plan (“LSM”) permits.  All permit 
applications have been deemed complete and have been recommended for conditional 
approval by the DENR staff. The GDP and WR permits are subject to hearing with public 
participation.  The  hearing  commenced  on  October  28,  2013  and  continued  through 
November 25, 2013, at which point it was determined that the hearing will resume once 
the NRC and EPA have ruled and set the federal surety. The LSM permit has been finalized 
subject to continuation of a hearing before the Board of Minerals and Environment, which 
commenced the week of September 23, 2013 and continued through November 5, 2013, 
at which point it was determined that the hearing will resume once the NRC and EPA have 
ruled and set the federal surety.  Subject to improved market conditions, the Company 
plans to re-commence the regulatory process with the DENR once the final EPA Class III 
and Class V UIC permits have been issued. 

On  July  8,  2014,  the  BLM  requested  additional  information  on  the  Company’s  plan  of 
operations  for  the  Dewey  Burdock  Project.  The  Company  submitted  the  requested 
information and anticipates that the BLM will approve the plan of operations in the near-
term now that the final contention on the Dewey Burdock Project NRC license has been 
resolved. 

Dewey Terrace Project (100% interest) – Wyoming, USA – adjacent to Dewey Burdock  

The  Company’s  100%  owned  Dewey  Terrace  Project  is  located  in  the  Weston  and 
Niobrara Counties of Wyoming.  The Company acquired this project primarily through 
the  staking  of  federal  mining  claims,  along  with  the  acquisition  of  lease  agreements. 
Through  mining  leases  and  mining  claims,  the  Dewey  Terrace  Project  is  comprised  of 
approximately 1,874 acres of surface rights and approximately 7,514 acres of net mineral 
rights.  The  Dewey  Terrace  Project  is located adjacent to the Company’s NRC  licensed 
Dewey Burdock Project. 

The  Company  has  identified  uranium  mineralization  at  the  Dewey  Terrace  Project 
through  the  review  and  analysis  of  historical  data  owned  by  the  Company  (the  “Data 
Set”).  The Data Set identified 259 mineralized drill holes indicating significant potential 
for a new resource area at the Dewey Terrace Project. Further, deposition is consistent 
with sand channel systems categorized within the Dewey Burdock Project and conditions 
that indicate possible ISR amenability. Several drill holes encountered multiple intercepts 
demonstrating a vertically stacked group of separate mineralized zones similar to those 
at  the  Dewey  Burdock  Project.    The  uranium  mineralization  covers  seven  separate 
mineralized zones over a trend of approximately 2.5 miles.  

As announced on October 31, 2017, the Data Set analysis has identified 91 mineralized 
drill holes with 129 intercepts equal to or exceeding a 0.2 GT cutoff using a 0.02% grade 
8
3
 grade of 0.062% and an average thickness of 7.4 feet.  The 
O
cutoff with an average eU
Company also identified 93 drill  holes with 112 intercepts that had GT values ranging 
from  0.1  to  0.2  GT  based  on  review  of  the  Data  Set.   These  intercepts  had  an  average 

11 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

thickness  of  4.1  feet  with  an  average  grade  of  0.041%  eU
holes reviewed range from barren to an average GT of 0.1.   

8
3
. The  remaining  187  drill 
O

The  Data  Set  includes  historical  drilling  information  that  has  been  reviewed  by  the 
Company’s  geological  team,  as  well  as  20  exploratory  drill  holes  completed  by  the 
Company in a previous exploration campaign. The exploratory drill holes completed by 
the  Company  confirm  the  presence  of  uranium  mineralization  at  the  Dewey  Terrace 
Project.  The  Company’s  review  of  the  records  and  information  within  the  Data  Set 
reasonably substantiate the validity of this information; however, the Company cannot 
directly  verify  the  accuracy  of  the  historical  data,  including  the  procedures  used  for 
sample  collection  and  analysis.    Therefore,  the  Company  encourages  investors  not  to 
place undue weight on these results. 

The  objective  of  the  Data  Set  analysis  is  to  identify  uranium  mineralization  in  a  cost-
effective  manner  in  the  vicinity  of  the  Company’s  Dewey  Terrace  and  Dewey  Burdock 
Projects.  The  Company  is  continuing  its  review  of  the  Data  Set  with  the  objective  of 
identifying additional uranium mineralization. 

Gas Hills Project (100% interest), Wyoming, USA 

The Company’s 100% owned Gas Hills Project is located in the historic Gas Hills uranium 
district  situated  45  miles  east  of  Riverton,  Wyoming.  The  Gas  Hills  Project  consists  of 
approximately  1,280  surface  acres  and  12,960  net  mineral  acres  of  unpatented  lode 
mining  claims,  a  State  of  Wyoming  mineral  lease,  and  private  mineral  leases,  within a 
brownfield site which has experienced extensive development including mine and mill 
site production.   
Summary of Mineral Resources  

In June 2017, a technical report was prepared by BRS Inc. on the Gas Hills Project titled 
“Amended  and  Restated  Gas  Hills  Uranium  Project,  Mineral  Resource  and  Exploration 
Target NI 43-101 Technical Report, Fremont and Natrona Counties, Wyoming, USA” (the 
“Gas Hills Report”) with an effective date of June 9, 2017. The Gas Hills Project contains 
8
3
 (2.4 million tons at an average 
O
indicated uranium resources of 4.7 million pounds U
8
3
8
3
 (2.3 
) and inferred uranium resources of 2.5 million pounds U
O
grade of 0.098% U
O
8
million tons at an average grade of 0.054% U
) at a 0.10 GT cut-off.  Mineral resources 
that are not mineral reserves do not have demonstrated economic viability. 

3
O

The  uranium  mineralization  is  contained  in  roll-front  deposits  hosted  by  arkosic 
sandstone beds of the Eocene Wind River Formation.  The deposits are stratabound and 
occur from the surface to depths of approximately 450 feet in areas amenable to open-pit 
mining, and to depths in excess of 1,200 feet, which may be amenable to ISR.  Based on 
areas of wide-spaced  limited  historical  drilling  and areas of past mine production, the 
Company  believes  that  there  is  sufficient  geological  evidence  to  interpret  that 
mineralization may extend from current mineral resource areas along identified trends. 
Based on a detailed review of previous work, the Company has outlined five high priority 

12 

 
 
 
 
 
 
 
 
  
  
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

exploration targets within the project for follow-up including Day Loma, Day Loma/Loco-
Lee, Loco-Lee, George-Ver, and Bullrush.  

Details  of  the  assumptions  and  parameters  used  with  respect  to  the  Gas  Hills  Report, 
including quality estimates and information on data verification, are available under the 
SEDAR profile of URZ Energy at www.sedar.com.  

Subsequent to issuing the Gas Hills Report, the Company commenced detailed ISR studies 
on  the  Gas  Hills  Project.  These  studies  focused  on  piezometric  surface  conditions  and 
permeability of the Wind River formation confined aquifer, the primary host of uranium 
mineralization at the Company’s Gas Hills Uranium Project.  The first study, announced 
by  URZ  Energy  on  May  1,  2018,  focused  on  piezometric  surface  conditions  and 
demonstrated  that  three  of  the  primary  deposits  at  the  Gas  Hills  property,  being  Day 
Loma, George-Ver and Loco-Lee, were principally located within a confined aquifer that 
contains current hydrostatic head well above the minimum requirements to allow for the 
successful use of ISR mining techniques.   

The second study focused on permeability (also referred to as hydraulic conductivity). A 
comprehensive review of pump test data for the Gas Hills Project and pump test data for 
other mining operations and planned mining operations in Wyoming proximal to the Gas 
Hills  Project  was  conducted  by  Hydro-Engineering  L.L.C  (“Hydro-Engineering”).    A 
summary of the review is presented below for each project: 

Project Name and Owner 

Hydraulic Conductivity 
Range (feet/day) 

Permeability Range (darcy) 

Gas Hills; Azarga 
Uranium 

Gas Hills (Peach); 
Cameco  

              1.0 to 5.7  

                  0.8 to 2.7 

              0.5 to 6.0 

                  0.3 to 2.89 

Lost Creek; Ur-Energy 

              0.27 to 2.78 

                  0.13 to 1.3 

Hydro-Engineering concluded that the hydraulic conductivity at the Gas Hills Project is 
comparable to hydraulic conductivity values at other ISR mining operations and planned 
mining operations in Wyoming proximal to the Gas Hills Project.  Thus, the permeability 
of the mineralized Wind River formation confined aquifer at Gas Hills is suitable for ISR 
uranium mining.  

The  favorable  report  on  permeability  coupled  with  the  favorable  piezometric  surface 
conditions confirms that these two important hydrologic parameters are suitable for ISR 
uranium mining.  The Company will continue to evaluate future ISR development options 
at the Gas Hills Project. 

13 

 
 
 
 
 
 
 
 
 
  
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

The Centennial Project (100% interest) – Colorado, USA 

The Company’s 100% owned Centennial Project is located in the western part of Weld 
County in north-eastern Colorado. Through property purchase and lease agreements, the 
Centennial Project is comprised of approximately 1,365 acres of surface rights and 6,238 
acres of net mineral rights.  

Historical  exploration  work  included  drilling,  recovery  tests,  water  well  tests  and 
environmental studies. At the request of the Colorado Division of Reclamation, Mining 
and Safety, the Company prepared and submitted an updated Site Characterization Plan 
in April 2009. All the required environmental surveys and studies have been completed 
and the draft reports have been received. The Company completed its application to the 
EPA for a Class I UIC Permit in November 2010. In December 2010, the EPA informed the 
Company that the application was deemed complete; however, the Company withdrew 
its application in the fourth quarter of 2018.  The EPA will retain the application should 
the  Company  wish to resume  the  process.   The  majority  of  the  major  mine  permit 
applications for the Centennial Project have not been prepared or submitted to date.    

In  August  2010,  a  NI  43-101  compliant  independent  PEA  (the  “Centennial  PEA”)  was 
prepared by SRK Consulting (U.S.), Inc. and Lyntek Incorporated with an effective date of 
June 2, 2010.  The Centennial PEA indicated that the Centennial Project can be developed 
using the ISR  method  and  resulted in a pre-tax net present value of $51.8  million  at a 
discount rate of 8% and an internal rate of return of 18%.  The Centennial PEA assumed 
8
3
uranium prices of $65/lb U
 and capital costs 
O
of  $71.1  million.    The  Centennial  PEA  included  indicated  uranium  resources  of 
8
3
 and inferred uranium resources of 2,325,514 pounds 
O
10,371,571 pounds at 0.09% U
8
3
at 0.09% U
 at a 0.20 GT cut-off and annual production of 700,000 lbs per annum, which 
O
resulted in a 14-year mine life.   

8
3
, cash operating costs of $34.95/lb U
O

Details  of  the  assumptions  and  parameters  used  with  respect  to  the  Centennial  PEA, 
including information on data verification, are set out in the Centennial PEA dated August 
6,  2010,  a  copy  of  which  is  available  under  the  Company’s  profile  on  SEDAR  at 
www.sedar.com.  The  Centennial  PEA  is  preliminary  in  nature  and  includes  inferred 
mineral resources that are considered too speculative geologically to have the economic 
considerations  applied  to  them  that  would  enable  them  to  be  categorized  as  mineral 
reserves.  There is no certainty that the Centennial PEA will be realized. Mineral resources 
that are not mineral reserves do not have demonstrated economic viability. 

Subsequent  to  the  Centennial  PEA  being  completed,  certain  lease  agreements  with 
respect to the Centennial Project were not renewed and certain parcels of redundant land 
at  the  Centennial  Project  were  sold;  however,  the  impact  to  the  Centennial  PEA  is 
immaterial. 

In  2006,  the  Company  entered  into  an  option  agreement,  as  amended,  to  purchase 
uranium rights on certain areas of the Centennial Project for consideration of $1,895,000 
plus  contingent  payments  of  $3,165,000.  Pursuant  to  the  agreement,  the  contingent 

14 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

payments are payable upon receipt of regulatory permits and licenses allowing uranium 
production on the area of the Centennial Project pertaining to these uranium interests.  
Further,  unless  otherwise  agreed,  if  the  Company  does  not  obtain  such  permits  and 
licenses by September 27, 2019, the uranium  rights, at the option of the seller, can be 
transferred back to the seller.  To date, the Company has neither obtained the required 
regulatory permits and licenses nor has the Company been able to renegotiate the option 
agreement.  However, the Company is attempting to renegotiate the option agreement 
and the seller has not exercised its option to have the uranium rights transferred back. 

As a result of the uncertainty surrounding this option agreement, which represents 5,760 
of  the  6,238  mineral  acres  at  the  Centennial  Project,  significant  doubt  over  the  future 
recoverability of the carrying value exists.  Accordingly, during the year ended December 
31,  2019,  the  Company  recognized  an  impairment  charge  of  $2,422,398  for  the 
Centennial Project. 

Juniper Ridge Project (100% interest), Wyoming, USA  

The Company’s 100% owned Juniper Ridge Project is located in the southwest portion of 
Wyoming, approximately 10 miles west of the town of Baggs. The Juniper Ridge Project 
consists of approximately 640 surface acres and 3,240 net mineral acres of unpatented 
lode  mining  claims  and  a  State  of  Wyoming  mineral  lease  and  is  located  within  a 
brownfield  site  which  has  experienced  extensive  exploration,  development,  and  mine 
production.   

In June 2017, a technical report was prepared by BRS Inc. and T.P. McNulty and Associates 
Inc.  on  the  Juniper  Ridge  Project  titled  “Juniper  Ridge  Uranium  Project,  Amended  and 
Restated  43-101  Mineral  Resource  and  Preliminary  Economic  Assessment  Technical 
Report”  (the  “Juniper  Ridge  PEA”)  with  an  effective  date  of  June  9,  2017.  The  Juniper 
8
3
  (5.1 
O
Ridge  Project  contains  indicated  uranium  resources  of  6.0  million  pounds  U
8
) and inferred uranium resources of 0.2 
million tons at an average grade of 0.058% U
8
3
) at a 0.10 GT 
O
million pounds U
cut-off. 

3
O
8
3
 (0.1 million tons at an average grade of 0.085% U
O

The  Juniper  Ridge  PEA  resulted  in  a  pre-tax  net  present  value  of  $27.3  million  at  a 
discount rate of  8%  and  an  internal  rate of return of 26% compared to a post-tax net 
present value of $19.9 million at a discount rate of 8% and an internal rate of return of 
22% based on open pit mining and heap leach extraction of uranium.  The Juniper Ridge 
8
3
PEA assumed uranium  prices  of $65/lb  U
,  total direct operating  costs  of  $39.77/lb 
O
U

8
3
 and capital expenditures of $36.7 million. 
O

Details of the assumptions and parameters used with respect to the Juniper Ridge PEA, 
including quality estimates and information on data verification, are available under the 
SEDAR profile of URZ Energy at www.sedar.com.  The Juniper Ridge PEA is preliminary 
in  nature;  it  includes  inferred  mineral  resources  that  are  considered  too  speculative 
geologically to have the economic considerations applied to them that would enable them 
to be categorized as mineral reserves.  There is no certainty that the Juniper Ridge PEA 

15 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

will  be  realized.    Mineral  resources  that  are  not  mineral  reserves  do  not  have 
demonstrated economic viability. 

While  local  mineralization  displays  some  of  the  characteristics  of  known  uranium 
deposits in the Gas Hills uranium district and in the Powder River Basin of Wyoming, the 
mineralization  at  the  Juniper  Ridge  Project  is  sandstone  hosted.  Data  sources  for  the 
estimation of uranium mineral resources for the Juniper Ridge Project consist of 2,716 
drill holes including radiometric equivalent data for 2,167 drill holes completed before 
2011, Uranium Spectral Analysis Tool assay data for 400 drill holes completed during the 
2011 drilling program, and radiometric equivalent and PFN assay data for 149 drill holes 
completed in 2012. 

The Company intends to continue to evaluate and review project geophysical logs and 
other data associated with the project to evaluate the possibility of future alternatives 
including updates to resource estimates and project economics. 

The Aladdin Project (100% interest) – Wyoming, USA 

The Aladdin Project is comprised of private leases that cover approximately 5,166 acres 
of  surface  rights  and  4,618  acres  of  net  mineral  rights  located  in  Wyoming  along  the 
Wyoming/South Dakota border on the northwestern flank of the Black Hills Uplift, within 
sandstones  of the  Lower  Cretaceous-age  Inyan Kara Group.    The Aladdin Project is  80 
miles northwest of the Dewey Burdock Project. Uranium resources at the Aladdin Project 
have  developed  within  the  same  host  rocks  that  contain  the  Dewey  Burdock  Project 
uranium resources. 

In  June  2012,  the  Company  completed  a  NI  43-101  compliant  technical  report  for  the 
Aladdin  Project,  with  an  effective  date  of  June  21,  2012,  describing  the  results  of  the 
Company’s  confirmation  drilling  program  and  continued  evaluation  of  the  historic 
exploration  drilling  data  from  the  Teton  Exploration  Company.  The  Aladdin  Project 
8
3
 and inferred 
O
contains indicated uranium resources of 1,038,023 pounds at 0.111% U
3
at  a  0.20  GT  cut-off.    Mineral 
O
uranium  resources  of  101,255  pounds  at  0.119%  U
resources that are not mineral reserves do not have demonstrated economic viability. 

8 

In  addition,  using  the  same  cut-off,  the  quantity  of  mineralization  for  the  exploration 
target was determined to be 5.0 to 11.0 million pounds of uranium, averaging 0.11% - 
8
3
0.12% U
.  In over 80% of the project area, the density of exploration drilling is light 
O
and insufficient to calculate resources. In these lightly explored areas, there is sufficient 
drill hole control for subsurface geochemical mapping and thirteen mineralized trends 
were identified. This estimation used a range of i) mineralized trend lengths, ii) widths of 
mineralization  and  iii)  grades  of  mineralization.    The  grade  and  quantity  of  this 
exploration  target  is  conceptual  in  nature  and  there  has  been  insufficient  exploration 
work performed with respect to the exploration target to define a NI 43-101 compliant 
resource. It is uncertain whether further exploration of the exploration target will result 
in the delineation of a NI 43-101 compliant resource.  

16 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Details of the assumptions and parameters used with respect to the Aladdin NI 43-101 
compliant  technical  report,  including  quality  estimates  and  information  on  data 
verification, are available under the Company’s profile on SEDAR at www.sedar.com.  

Subsequent to the NI 43-101 compliant technical report being completed, certain lease 
agreements/claims  were  not  renewed;  however,  the  impact  to  the  Aladdin  NI  43-101 
technical report is immaterial. 

The Company is currently evaluating the Aladdin Project in order to determine how to 
maximize the value that can be extracted from this project. 

Kyzyl Ompul Project (93.1% interest sold in October 2019) – Kyrgyz Republic 

In October 2019, the Company sold its 93.1% interest in UrAsia in Kyrgyzstan Limited 
Liability  Company  (“UrAsia”)  to  Central  Asian  Uranium  Company  Limited  Liability 
Company (“Central”) for $232,750.  In addition, UrAsia granted the Company a 1.862% 
NSR  royalty  on  any  future  uranium  production  from  the  Kyzyl  Ompul  Project  up  to 
$4,655,000.  UrAsia held a 100% interest in the Kyzyl Ompul Project. 

In  April  2018,  as  amended,  UrAsia  entered  into  an  earn-in  agreement  (the  “Earn-in 
Agreement”)  with  Central  pursuant  to  which  Central  had  an  option  to  earn  a  100% 
interest in the Kyzyl Ompul Project in exchange for $5,850,000 in cash payments and a 
commitment to fund $1,500,000 of exploration and development expenditures through 
December 1, 2020.  During the year ended December 31, 2019 and 2018, Central made 
cash payments of $130,000 and $290,000, respectively, to the Company under the Earn-
in Agreement. 

In May 2019,  the Kyrgyz  Republic’s parliament voted to ban uranium exploration and 
mining in the country.  The Kyzyl Ompul Project exploration license was subsequently 
suspended due to force majeure circumstances, among other reasons, resulting from the 
Kyrgyz Republic government’s actions.  The Company determined that these events in 
the  Kyrgyz  Republic  cast  significant  doubt  over  the  future  validity  of  the  Company’s 
exploration  license  on  the  Kyzyl  Ompul  Project  as  well  as  on  the  future  cash  flows 
expected under the Earn-in Agreement.  Accordingly, during the year ended December 
31,  2019,  the  Company  recognized  an  impairment  charge  of  $4,140,444  for  the  Kyzyl 
Ompul Project. 

17 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

QUALIFIED PERSON 

Disclosure  of  a  scientific  or  technical  nature  in  this  MD&A  has  been  reviewed  and 
approved by John Mays, P.E., Chief Operating Officer and a “qualified person” as defined 
under NI 43-101.
SELECTED ANNUAL INFORMATION 

Year  
Ended  
December 
31, 2019 

Year  
Ended  
December 
31, 2018 

Year  
Ended  
December 
31, 2017 

Statement of Loss:  
Net revenues 
Net loss 
Net loss per share, 
basic and diluted 
Financial Position:  
Total assets 
Non-current liabilities 
Dividends 

$Nil 
$7,737,996 

$Nil 
$2,408,725 

$Nil 
$5,280,632 

$0.05 

$0.02 

$0.07 

$41,850,626  $47,304,353  $33,695,520 
$4,854,886 
$3,769,217 
$Nil 
$Nil 

$6,229,824 
$Nil 

The net loss for the year ended December 31, 2019 included a $6.6 million impairment of 
exploration and evaluation assets related to the Centennial and Kyzyl Ompul projects. 

The net loss for the year ended December 31, 2017 included a $6.3 million impairment of 
exploration  and  evaluation  assets  related  to  Kyzyl  Ompul  project  and  an  associated 
$2,236,000 deferred income tax recovery. 

18 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

RESULTS OF OPERATIONS – YEAR ENDED DECEMBER 31, 2019 

The  consolidated  net  loss  for  the  year  ended  December  31,  2019  was  $8,289,158 
compared to $2,408,725 for the year ended December 31, 2018. 

The  significant  changes  between  the  current  period  and  the  comparative  period  are 
discussed below: 

Administrative  expenses  totaled  $1,943,285  for  the  year  ended  December  31,  2019 
compared  to  $2,040,580  for  the  year  ended  December  31,  2018.    The  decrease  in 
administrative  expenses  primarily  related  to  reduced  corporate  administration due  to 
cost cutting measures. 

During  the  year  ended  December  31,  2019,  the  Company  recognized  an  impairment 
charge of $2,422,398 for the Centennial Project. 

Finance  costs  totaled  $9,734  for  the  year  ended  December  31,  2019  compared  to 
$154,913  for  the  year  ended  December  31,  2018.    Finance  costs  for  2019  related  to 
interest expense on the Company’s operating lease obligations while the finance costs for 
2018 related primarily to interest expense on the $1,776,000 shareholder loan which was 
settled in July 2018 through the issuance of common shares of the Company. 

The Company recognized  an  unrealized gain on  warrant liabilities of  $371,983 for the 
year ended December 31, 2019 compared to $51,789 for the year ended December 31, 
2018. 

In October 2019, the Company sold its Kyzyl Ompul project located in Kyrgyzstan.  The 
Company’s operations in Kyrgyzstan represented a separate geographical segment and 
accordingly the Company has presented these operations as discontinued operations for 
years ended December 31, 2019 and 2018.  The net loss from discontinued operations 
for the  year ended  December  31,  2019  was  $3,763,180  compared  to  $117,560  for the 
year  ended  December  31,  2018.    The  net  loss  from  discontinued  operations  for  the 
current year includes: 

• 
• 

• 
• 

an impairment charge of $4,140,444 for the Kyzyl Ompul Project; 
a reversal of deferred income tax liabilities of $999,597 on the impairment charge 
to the Kyzyl Ompul Project; 
a foreign exchange loss of $1,080,330; and 
a gain on sale of UrAsia of $499,173. 

19 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

SUMMARY OF QUARTERLY RESULTS  

The following tables provide selected quarterly financial information for the most recent 
eight quarters.  

3 Months
Ended

3 Months
Ended

December 31, September 30,

(1)

2019

2019 

3 Months
Ended
June 30,
(2)

2019 

3 Months
Ended
March 31,

2019

Total revenues

$              
-

$              
-

$              
-

$              
-

Net loss

$    

(170,830)

$ 

(2,882,698)

$ 

(4,492,364)

$    

(192,104)

Net loss per share, 
basic and diluted

$           

(0.00)

$           

(0.01)

$           

(0.03)

$          (0.00)

3 Months
Ended

3 Months
Ended

December 31, September 30,

2018

2018

3 Months
Ended
June 30,
2018

3 Months
Ended
March 31,
2018

Total revenues

$              
-

$              
-

$              
-

$              
-

Net loss

$    

(986,839)

$    

(557,452)

$    

(238,442)

$    

(625,992)

Net loss per share, 
basic and diluted

$           

(0.01)

$          (0.00) $          (0.00)

$           

(0.01)

(1)  The three months ended September 30, 2019 included an impairment charge 
of $2,422,398 for the Centennial Project.
(2)  The three months ended June 30, 2019 included an impairment charge of 
$4,140,444 for the Kyzyl Ompul Project.

20 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

FOURTH QUARTER 2019 

The Company began the fourth quarter with a cash balance of $343,778.  During the three 
months  ended  December  31,  2019,  the  Company  expended  $180,280  on  operating 
activities, net of working capital changes, expended $167,245 on investing activities, and 
received  $191,409  from  financing  activities,  with  a  negative  $3,215  effect  of  foreign 
exchange on cash to end the quarter and the year with $184,447 cash. 
LIQUIDITY AND CAPITAL RESOURCES 

The  Company  began  the  fiscal  year  with  a  cash  balance  of  $352,001.    During  the  year 
ended December  31,  2019,  the  Company expended  $1,489,506 on  operating activities, 
net of working capital changes, expended $1,115,148 on investing activities, and received 
$2,441,025 from financing activities, with a negative $3,925 effect of foreign exchange on 
cash to end at December 31, 2019 with a cash balance of $184,447. 

In March 2019, the Company closed a non-brokered private placement for gross proceeds 
of $2,266,169 (C$3,014,391) through the issuance of 13,106,046 units at a price of C$0.23 
per unit.  Each unit consists of one common share and one-half of one share purchase 
warrant.  Each whole warrant entitles the holder thereof to purchase one common share 
at a price of C$0.31 per share until March 20, 2022.  The Company paid cash finder’s fees 
of $5,696 and other share issue costs of $10,857. 

The Company’s capital risk management objectives have been established to safeguard 
the Company’s ability to continue as a going concern in order to support the Company’s 
permitting and exploration and development of its mineral properties and to maintain a 
flexible  capital  structure  which  optimizes  the  cost  of  capital  at  an  acceptable  risk.  To 
facilitate  the  management  of  its  capital  requirements,  the  Company  prepares  annual 
expenditure  budgets  that  are  updated  as  necessary  depending  on  various  factors, 
including capital deployment, progress on permitting, results from the exploration and 
development of its properties and general industry conditions.  The annual and updated 
budgets are approved by the Board of Directors.  

To date, the Company has not generated revenues from operations and is currently in the 
exploration  and  development  stage.    As  at  December  31,  2019,  the  Company  had  a 
working capital deficit of $630,518 and an accumulated deficit of $26,988,501 and will 
continue incurring losses for the foreseeable future.  Additional funding will be required 
by  the  Company  to  complete  its  strategic  objectives  and  continue  as  a  going  concern. 
There  is  no  certainty  that  additional  financing,  at  terms  that  are  acceptable  to  the 
Company,  will  be  available.  Further,  at  present,  the  COVID-19  pandemic  is  negatively 
impacting financial markets globally and this may adversely affect the Company’s ability 
to raise capital for future operations and exploration and development of the Company’s 
mineral properties.  The Company has successfully raised financing in the past and will 
continue  to  assess  available  alternatives;  however,  there  is  no  assurance  that  the 
Company will be able to raise additional funds in the future. These material uncertainties 
cast significant doubt on the Company’s ability to continue as a going concern. 

21 

 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

At  the  date  of  this  MD&A,  the  Company  has  10,454,490  exercisable  share  purchase  
warrants outstanding at exercise prices ranging from C$0.31 to C$0.36 and 11,795,000 
exercisable stock options outstanding at exercise prices ranging from C$0.075 to C$0.36, 
that if exercised will raise additional capital for the Company. 
CONTRACTUAL OBLIGATIONS AND COMMITMENTS 

Within 1 year

2-4 years

Over 4 years

Total

Annual license payments *
Centennial option 
agreement **
Dewey Burdock option 
agreements

$           

540,356

$           

390,097

$       

1,338,783

$       

2,269,236

-

-

3,165,000

3,165,000

62,500
602,856

$           

255,000
645,097

$           

1,638,750
6,142,533

$       

1,956,250
7,390,486

$       

* annual license payments include lease, mineral claim, and exploration license payments 
** the contingent payments are payable upon receipt of regulatory permits and licenses 
allowing uranium production on the area of the Centennial Project pertaining to these 
uranium interests.  Further, since the required licenses and permits were not received by 
September 27, 2019, the uranium rights, at the option of the seller, can be transferred 
back  to  the  seller.    The  Company  is  attempting  to  renegotiate  the  Centennial  Project 
option agreement. 

Certain  of  the  Company’s  commitments  may  provide  the  Company  with  the  ability  to 
avoid  funding  those commitments;  however,  the  Company  discloses  the  contractual 
maturities of the Company's commitments based on management's intent. 

22 

 
 
 
 
 
 
 
 
 
 
 
 
 
                        
                        
          
          
                
              
          
          
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

FINANCIAL INSTRUMENTS AND RISK MANAGEMENT 

Financial Instruments 

Financial  instruments  are  classified  into  one  of  the  following  categories:  fair  value 
through  profit  or  loss;  fair  value  through  other  comprehensive  income  (loss);  or,  at 
amortized cost. The carrying values of the Company’s financial instruments are classified 
into the following categories: 

As at December 31,

Financial assets

Amortized cost

Cash
Restricted cash
Reclamation bonds

Financial liabilities

Amortized cost

2019

2018

$                      

$                      

$                      

184,447
22,716
-
207,163
As at December 31,

$                      

352,001
39,963
99,000
490,964

2019

2018

Trade and other payables
Decommissioning liabilities
Operating lease obligations

Fair value through profit or loss

$                      

863,864
251,550
115,459

$                  

1,452,085
223,442
-

Warrant liabilities

$                  

265,029
1,495,902

$                  

247,654
1,923,181

23 

 
 
 
 
 
 
 
 
 
 
 
                           
                           
                                   
                           
                         
                         
                         
                                   
 
 
 
 
 
                         
                         
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Fair value 

The fair value of financial assets and financial liabilities measured at amortized cost is 
determined in accordance with generally accepted pricing models based on discounted 
cash  flow  analysis  or  using  prices  from  observable  current  market  transactions.    The 
Company  considers  that  the  carrying  amount  of  all  its  financial  assets  and  financial 
liabilities measured at amortized cost approximates their fair value. 

The Company’s financial instruments recorded at fair value require disclosure about how 
the  fair  value  was  determined  based  on  significant  levels  of  inputs  described  in  the 
following hierarchy: 

• 

• 

• 

Level 1 fair value measurements are those derived from quoted prices in active 
markets for identical assets or liabilities. 
Level  2  fair  value  measurements  are  those  derived  from  inputs  other  than 
quoted prices included within Level 1, that are observable either directly or 
indirectly.  
Level 3 fair value measurements are those derived from valuation techniques 
that include inputs that are not based on observable market data. 

The fair value of the Company’s warrant liabilities is recorded at fair value using Level 3 
of the fair value  hierarchy.  The carrying value of the warrant liabilities is determined 
using the Black-Scholes option pricing model. 

The carrying values of cash and trade and other payables approximate their fair values 
because  of  the  short-term  nature  of  these  financial  instruments  and  are  classified  as 
financial assets and liabilities at amortized cost and are reported at amortized cost. 

The carrying  values  of  restricted cash, reclamation  bonds, decommissioning  liabilities, 
and  operating  lease  obligations  approximate  their  fair  values  and  are  classified  as 
financial assets and liabilities at amortized cost and are reported at amortized cost. 
Financial risk management objectives and policies

The financial risk arising from the Company’s operations are market risk, credit risk, and 
liquidity risk.  These risks arise from the normal course of operations and all transactions 
undertaken  are  to  support  the  Company’s  ability  to  continue as  a  going  concern.    The 
risks  associated  with  these  financial  instruments  and  the  policies  on  how  to  mitigate 
these risks are set out below.  Management of the Company manages and monitors these 
exposures  to  ensure  appropriate  measures  are  implemented  on  a  timely  and  effective 
manner. During the year ended December 31, 2019, there were no significant changes in 
the  Company’s  financial  risk  management  objectives  and  policies.  The  Company’s  risk 
exposure and the impact on the Company’s financial instruments are summarized below:

24 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Market risk 

Market risk is the risk that the fair value of the future cash flows of a financial instrument 
will fluctuate due to changes in market factors. Market risk comprises three types of risks: 
currency risk, price risk and interest rate risk: 

Currency risk 

Currency risk is the risk that the fair values or future cash flows of the Company’s 
financial  instruments  will  fluctuate  because  of  changes  in  foreign  currency 
exchange rates. The Company is exposed to currency risk through financial assets 
and  liabilities  denominated  in  currencies  other  than  the  United  States  Dollar.  
Management  believes  the  currency  risk  related  to  currency  conversions  is 
minimal and therefore, does not hedge its currency risk. 

Price risk 

Price  risk  is  the  risk  that  the  fair  value  of  future  cash  flows  of  the  Company’s 
financial  instruments  will  fluctuate  because  of  changes  in  market  prices.  The 
Company is exposed to the risk of fluctuations in prevailing market prices for its 
uranium  products.    However,  as  the  Company  is  currently  an  exploration  and 
development stage company, the risk is insignificant. 

Interest rate risk 

Interest  rate  risk  is  the  risk  that  the  fair  values  and  future  cash  flows  of  the 
Company will fluctuate because of changes in market interest rates. The Company 
is  exposed  to  interest  rate  risk  to  the  extent  that  the  cash  maintained  at  the 
financial institutions is subject to a floating rate of interest. The interest rate risk 
on cash is not significant. 

Credit risk 

Credit risk is the risk of potential loss to the Company if the counterparty to a financial 
instrument fails to meet its contractual obligations. 

The Company is exposed to credit risk associated with its cash. The Company’s maximum 
exposure to credit risk is equal to the carrying amount of its cash. 

The Company’s credit risk on cash arises from default of the counterparty. The Company 
limits  its  exposure  to  counterparty  credit  risk  on  cash  by  only  dealing  with  financial 
institutions with high credit ratings.  

25 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Liquidity risk 

Liquidity  risk  is  the  risk  that  the  Company  will  not  be  able  to  settle  or  manage  its 
obligations  associated with  financial liabilities.   The Company’s  approach  to  managing 
liquidity is to evaluate current and expected liquidity requirements under both normal 
and stressed conditions to ensure that it maintains sufficient reserves of cash, access to 
financing facilities or access to cash generating opportunities, such as the liquidation of 
non-core and redundant assets to meet expected expenditures.  The Company prepares 
annual expenditure budgets that are updated as necessary depending on various factors, 
including capital deployment, progress on permitting, results from the exploration and 
development of its properties and general industry conditions. The annual and updated 
budgets are approved by the Board of Directors. 

The Company’s current and expected remaining contractual maturities for its financial 
liabilities with agreed repayment periods are presented below.  The table includes the 
undiscounted cash flows of financial liabilities based on the earliest date on which the 
Company can be required to satisfy the liabilities.  

As at December 31, 2019

1-3 months

Trade and other payables
Operating lease obligations

$        

$        

728,864
15,573
744,437

1-5 years

Total

$       

70,000
124,526
194,526

$    

$      

863,864
180,709
1,044,573

$   

3 months - 
1 year

$        

65,000
40,610
105,610

$     

26 

 
 
 
 
 
 
 
 
 
 
 
 
             
          
       
         
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

RELATED PARTY TRANSACTIONS AND BALANCES 

Related party transactions 

During  the  year  ended  December  31,  2019,  the  Company  recorded  related  party 
transactions with management including: 

• 

The  issuance  of  800,000  common  shares  to  executive  management  of  the 
Company to settle employee remuneration. 

During  the  year  ended  December  31,  2018,  the  Company  recorded  related  party 
transactions with directors, management and shareholders including: 

• 

• 

• 

• 

• 

Interest  accruing  of  $143,219  to  certain  shareholders  of  the  Company  on  the 
Shareholders’ Loan; 
The issuance of 11,269,243 common shares valued at $2,201,024 in full and final 
settlement of the Shareholders’ Loan; 
The issuance of 186,512 common shares to a shareholder of the Company to settle 
of trade and other payables of $36,169; 
The  issuance  of 578,822  common shares  to  a director  of  the  Company  to settle 
trade and other payables of $187,500; and 
The  issuance  of  450,000  common  shares  to  executive  management  of  the 
Company to settle employee remuneration. 

Key management personnel compensation 

The remuneration of the Company’s directors and other key management personnel, who 
have the authority and responsibility for planning, directing and controlling the activities 
of the Company, consisted of the following: 

Year ended December 31,
2019
2018

Salaries and benefits *
Consulting and professional fees
Share-based compensation

$                      

$                      

837,365
161,881
207,595
1,206,841

841,476
139,926
200,791
1,182,193

$                  

$                  

*  Salaries  and  benefits  are  included  in  administrative  expenses  and  exploration  and 
evaluation assets. 

27 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         
                         
                         
                         
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

Related party liabilities 

As at December 31,

2019

2018

Trade and other payables - current
Trade and other payables - non-current

$                      

$                      

276,042
70,000
346,042

176,422
150,000
326,422

$                      

$                      

Included in trade and other payables as at December 31, 2019 and 2018 is $346,042 and 
$326,422, respectively, owing to related parties of the Company, of which $170,000 and 
$230,000, respectively, is owed to a former director of the Company.  On February 14, 
2018, the Company entered into an amended severance agreement with this director to 
pay the remaining  severance  payments over 49 months, whereby the amount  payable 
was increased  to  $370,000.    During the year ended December 31,  2019 and  2018, the 
Company  paid  the  former  director  $60,000  and  $140,000,  respectively,  towards  the 
outstanding balance.  The Company has classified $100,000 as current and $70,000 as 
non-current  as  at  December  31,  2019  and  $80,000  as  current  and  $150,000  as  non-
current  as  at  December  31,  2018.    In  June  2018,  the  Company  settled  other  deferred 
compensation  of  $187,500  with  this  same  former  director  through  the  issuance  of 
578,822 common shares of the Company.
OUTSTANDING SHARE DATA AS AT THE DATE OF THIS MD&A 

The  Company  has  authorized  the  issuance  of  an  unlimited  number  of  common  and 
preferred shares with no par value.  As at December 31, 2019 and through the date of this 
MD&A,  the  following  common  shares,  share  purchase  warrants  and  stock  options  are 
issued and outstanding: 

Balance, December 31, 2019 
Issuance of shares for ESPP 
Issuance of shares for DSA 
Balance as at the date of this 
MD&A 

Common 
Shares 
185,543,926 
457,618 
87,543 

Share Purchase 
Warrants 

10,454,490 
- 
- 

Stock  
Options 
14,622,500 
- 
- 

186,089,087 

10,454,490 

14,622,500 

28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                           
                         
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

USE OF ACCOUNTING ESTIMATES, JUDGEMENTS AND ASSUMPTIONS 

Information about judgments and estimates in applying accounting policies that have the 
most  significant  effect  on  the  amounts  recognized  in  the  consolidated  financial 
statements are as follows: 
Liquidity and going concern assumption 

In the determination of the Company’s ability to meet its ongoing obligations and future 
contractual commitments management relies on the Company’s planning, budgeting and 
forecasting  process  to  help  determine  the  funds  required  to  support  the  Company’s 
normal operations on an ongoing basis and its expansionary plans.  The key inputs used 
by  the  Company  in  this  process  include  forecasted  capital  deployment,  progress  on 
permitting, results from the exploration and development of its properties and general 
industry conditions.  Changes in these inputs may alter the Company’s ability to meet its 
ongoing obligations and future contractual commitments and could result in adjustments 
to the amounts and classifications of assets and liabilities should the Company be unable 
to continue as a going concern. 
Indicators of impairment of exploration and evaluation assets 

In accordance with the Company’s accounting policy for its exploration and evaluation 
assets, expenditures on its uranium properties are capitalized. There is no certainty that 
the expenditures made by the Company in the exploration of its property interests will 
result  in  discoveries  of  commercial  quantities  of  uranium.  The  Company  applies 
judgment  to  determine  whether  indicators  of  impairment  exist  for  these  capitalized 
costs. 

Management  uses  several  criteria  in  making  this  assessment,  including  the  period  for 
which  the  Company  has  the  right  to  explore,  expected  renewals  of  exploration  rights, 
whether substantive expenditures on further exploration and evaluation of its properties 
are budgeted, and evaluation of the results of exploration and evaluation activities up to 
the reporting date. 
Carrying value of exploration and evaluation assets 

If any indicators of impairment are noted then management reviews the carrying value 
of the Company’s exploration and evaluation assets to determine whether an impairment 
charge  should  be  recorded  on  any  of  its  projects.    Management  determines  the 
recoverable amount of its individual exploration and evaluation assets using the higher 
of  fair  value  less  costs  to  sell  or  value-in-use.    This  determination  and  the  individual 
assumptions require that management decide whether impairment should be recorded 
based  on  the  best  available  information  at  each  reporting  period.    Changes  in  these 
assumptions may alter the results of impairment testing, impairment charges recognized 
in profit or loss and the resulting carrying amounts of assets. 

29 

 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

During the year ended December 31, 2019, the Company recorded an impairment charge 
of  $4,140,444  on  its  Kyzyl  Ompul  project  in  Kyrgyzstan  and  an  impairment  charge  of 
$2,422,398 on its Centennial project in Colorado. 
Capitalization of exploration and evaluation costs  

Management has determined that exploration and evaluation costs incurred or acquired 
during the year will have future economic benefits and are economically recoverable. In 
making  this  judgment,  management  has  assessed  various  sources  of  information 
including, but not limited to, the geologic and metallurgic information, scoping studies, 
preliminary  economic  assessments,  proximity  of  operating  facilities,  operating 
management expertise and existing permits. 
Determining if an acquisition is a business combination or an asset acquisition 

As  required  by  IFRS  3  Business  Combinations  (“IFRS  3”),  the  Company  is  required  to 
determine whether the acquisition of URZ Energy should be accounted for as a business 
combination or an asset acquisition.  Under IFRS 3, the components of a business must 
include inputs, processes and outputs. Management has determined that URZ Energy did 
not include all the necessary components of a business. Accordingly, the acquisition of 
URZ Energy has been recorded as an acquisition of URZ’s net assets, consisting of URZ 
Energy’s exploration and evaluation assets and working capital.   
Identifying the acquirer in an acquisition 

As required by IFRS 3 and IFRS 10 Consolidated Financial Statements, the Company is 
required  to  determine  whether  it  is  the  acquirer  or  acquiree  in  the  URZ  Energy 
acquisition.    The  acquirer  is  the  entity  that  obtains  control  of  the  acquiree  in  the 
acquisition.  If it is not clear which company is the acquirer, additional information must 
be considered, such as the combined entity’s relative voting rights, existence of a large 
minority voting interest, composition of the governing body and senior management, and 
the  terms  behind  the  exchange  of  equity  interests.    Management  has  determined  that 
Azarga Uranium is the acquirer of URZ Energy. 
Determination of asset and liability fair values  

Business combinations and asset acquisitions require judgment and estimates to be made 
at the date of acquisition in relation to determining asset and liability fair values.  The 
information  necessary  to  measure  the  fair  values  as  at  the  acquisition  date  of  assets 
acquired  and  liabilities  assumed  requires  management  make  certain  judgments  and 
estimates about future events, including but not limited to estimates of mineral resources 
acquired, exploration potential, future operating costs and capital expenditures, future 
metal prices, and long-term foreign exchange rates. 

30 

 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

RECENT ACCOUNTING PRONOUNCEMENTS 

Adoption of new standards, interpretations and amendments 

The Company adopted the requirements of IFRS 16 – Leases (“IFRS 16”) as of January 1, 
2019.    IFRS  16  applies  a  control  model  to  the  identification  of  leases,  distinguishing 
between a lease and a service contract on the basis of whether the customer controls the 
leased asset. For assets that meet the definition of a lease, IFRS 16 requires a single, on-
balance sheet accounting model similar to finance lease accounting, with exceptions for 
short-term leases, leases of low value assets, and mineral exploration leases.  Accordingly, 
IFRS  16  applies  only  to  the  Company’s  office  leases.    The  Company  has  applied  the 
modified retrospective approach in adopting IFRS 16. 

On January 1, 2019 the Company recorded right-of-use assets totaling $152,214 with a 
corresponding entry to operating lease obligations.  The Company calculated the present 
value of the minimum lease payments using an incremental borrowing rate of 7% and an 
exchange rate of $/C$ 1.3642.   Thereafter, the right-of-use assets are depreciated on a 
straight-line basis over the term of the leases, which range from 2 to 5 years. 
Standards issued but not yet effective  

A number of new standards, amendments to standards and interpretations are not yet 
effective as of December 31, 2019 and have not been applied in preparing the Company’s 
consolidated financial statements.  The standards are not expected to materially impact 
the Company’s financial position or results of operations. 
PROPOSED TRANSACTIONS 

As  is  typical  of  the  mineral  exploration  and  development  industry,  the  Company  is 
continually  reviewing  potential  acquisition,  investment  and  joint  venture  transactions 
and opportunities that could enhance shareholder value. There is currently no proposed 
asset or business acquisitions or dispositions, other than those discussed in this MD&A 
and those in the ordinary course, before the Board of Directors for consideration. While 
we  remain  focused  on  our  plans  to  continue  exploration  and  development  on  our 
material property, should we enter into agreements in the future on new properties, we 
may be required to make cash payments and complete work expenditure commitments 
under those agreements. 

31 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

DISCLOSURE CONTROLS AND PROCEDURES 

Disclosure controls and procedures are designed to provide reasonable assurance that 
information required to be disclosed by the Company in its annual filings, interim filings 
or  other  reports  filed  or  submitted  by  it  under  securities  legislation  is  recorded, 
processed, summarized and reported within the time periods specified in the securities 
legislation  and  include  controls  and  procedures  designed  to  ensure  that  information 
required  to  be  disclosed  by  the  Company  in  its  annual  filings,  interim  filings  or  other 
reports filed or submitted under securities legislation is accumulated and communicated 
to the Company’s management, including its CEO and CFO, as appropriate to allow timely 
decisions regarding required disclosure. 

Management, including the CEO and CFO, has evaluated the effectiveness of the design 
and operation of the Company’s disclosure controls and procedures.  As of December 31, 
2019, the CEO and CFO have each concluded that the Company’s disclosure controls and 
procedures, as required by the applicable rules of the Canadian Securities Administrators 
(or Canadian securities regulatory authorities), are effective to achieve the purpose for 
which they have been designed. 

It should be noted that while the  Company’s CEO and CFO believe that the Company’s 
disclosure controls and processes will provide a reasonable level of assurance and that 
they  are  effective,  they  do  not  expect  that  the  disclosure  controls  and  processes  will 
prevent  all  errors  and  frauds.  A  control  system,  no  matter  how  well  conceived  or 
operated, can provide only reasonable, not absolute assurance that the objectives of the 
control system are met.  
INTERNAL CONTROLS OVER FINANCIAL REPORTING 

The Company’s management, with the participation of the Company’s CEO and CFO, are 
responsible  for  establishing  and  maintaining  adequate  internal  control  over  financial 
reporting. The Company’s internal control over financial reporting is a process designed 
to provide reasonable assurance regarding the reliability of financial reporting and the 
preparation of financial statements for external purposes in accordance with IFRS. Any 
system  of  internal  control  over  financial  reporting,  no  matter  how  well  designed,  has 
inherent limitations. As a result, even those systems determined to be effective can only 
provide reasonable assurance regarding the preparation of financial statements. Internal 
controls over financial reporting are designed to provide reasonable assurance regarding 
the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  in 
accordance with IFRS. Management is also responsible for the design of the Company’s 
internal  controls  over  financial  reporting  in  order  to  provide  reasonable  assurance 
regarding the reliability of financial reporting and the preparation of financial statements 
for external purposes in accordance with IFRS. 

The Company’s internal controls over financial reporting include policies and procedures 
that: pertain to the maintenance of records that, in reasonable detail accurately and fairly 

32 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

reflect  the  transactions  and  disposition  of  assets;  provide  reasonable  assurance  that 
transactions are recorded as necessary to permit preparation of the financial statements 
in  accordance  with  IFRS  and  that  receipts  and  expenditures  are  being  made  only  in 
accordance  with  authorization  of  management  and  directors  of  the  Company;  and 
provide reasonable assurance regarding prevention or timely detection of unauthorized 
acquisition, use or disposition of assets that could have a material effect on the financial 
statements. 

Because  of  their  inherent  limitations,  internal  controls  over  financial  reporting  can 
provide  only  reasonable  assurance  and  may  not  prevent  or  detect  misstatements. 
Furthermore, projections of any evaluation of effectiveness to future periods are subject 
to the risk that controls may become inadequate because of changes in conditions, or that 
the degree of compliance with the policies or procedures may deteriorate. 

The  Company’s  management,  under  the  supervision  of  the  CEO  and  the  CFO,  has 
evaluated the effectiveness of the Company’s internal controls over financial reporting 
using  the  framework  and  criteria  as  required  by  the  applicable  rules  of  the  Canadian 
Securities Administrators (or Canadian securities regulatory authorities). Based on this 
evaluation,  management  has  concluded  that  internal  controls  over  financial  reporting 
were effective as at December 31, 2019. 

There were no changes in the Company’s internal controls over financial reporting that 
occurred during the year ended December 31, 2019, that have materially affected, or are 
likely to materially affect, the Company’s internal control over financial reporting. 
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS 

This MD&A may include or incorporate by reference certain statements or disclosures 
that  constitute  “forward-looking  information”  under  applicable  securities  laws.    All 
information,  other  than  statements  of  historical  fact,  included  or  incorporated  by 
reference  in  this  MD&A  that  addresses  activities,  events  or  developments  that  the 
Company  or  its  management  expects  or  anticipates  will  or  may  occur  in  the  future 
constitute  forward-looking  information.  Forward-looking  information  is  provided 
through  statements  that  are  not  historical  facts  and  are  generally,  but  not  always, 
identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, 
“projects”,  “potential”  and  similar  expressions,  or  that  events  or  conditions  “will”, 
“would”, “may”, “could” or “should” occur or continue.  These forward-looking statements 
are  based  on  certain  assumptions  and  analyses  made  by  the  Company  and  its 
management  in  light  of  its  experience  and  its  perception  of  historical  trends,  current 
conditions  and  expected  future  developments,  as  well  as  other  factors  it  believes  are 
appropriate in the circumstances.   

Although the Company believes such forward-looking information and the expectations 
expressed in them are based on reasonable assumptions, investors are cautioned that any 
such information and statements are not guarantees of future realities and actual realities 

33 

 
 
 
 
 
 
 
 
 
 
 
AZARGA URANIUM CORP. 
Management’s Discussion and Analysis 

For the year ended December 31, 2019 

or  developments  may  differ  materially  from  those  projected  in  forward-looking 
information and statements. Whether actual results will conform to the expectations of 
the Company is subject to a number of risks and uncertainties, including those risk factors 
listed  under  “Risk  Factors”  in  the  Company’s  Annual  Information  Form  and  the 
documents  incorporated  herein  by  reference.    In  particular,  if  any  of  the  risk  factors 
materialize, the expectations, and the predictions based on them, of the Company may 
need  to  be  re-evaluated.    Consequently,  all  of  the  forward-looking  information  in  this 
MD&A  and  the  documents  incorporated  herein  by  reference  is  expressly  qualified  by 
these cautionary statements and other cautionary statements or factors contained herein 
or in documents incorporated by reference herein, and there can be no assurance that 
the actual results or developments anticipated by the Company will be realized or, even 
if substantially realized, that they will have the expected consequences for the Company.   

Forward-looking  statements  are  based  on  the  beliefs,  estimates  and  opinions  of  the 
Company’s management on the date the statements are made. Unless otherwise required 
by  law,  the  Company  expressly  disclaims  any  intention  and  assumes  no  obligation  to 
update or revise any forward-looking statements in the event that management’s beliefs, 
estimates  or  opinions,  or  other  factors,  should  change,  whether  as  a  result  of  new 
information, future events or otherwise, and the Company does not have any policies or 
procedures in place concerning the updating of forward-looking information other than 
those required under applicable securities laws. Accordingly, readers should not place 
undue reliance on forward-looking statements or forward-looking information. 

34